This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_COLORECTAL_EXALLC for full statistics.
Colorectal cancer
C3_COLORECTAL
colorectal cancer: A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
9870 |
6. Filter based on genotype QC (FinnGen only) |
9870 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Colorectal cancer
based on the number of shared cases.
Similar with more cases:
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9870 | 4167 | 5703 |
| Unadjusted period prevalence (%) | 2.05 | 1.42 | 2.51 |
| Median age at first event (years) | 68.43 | 66.84 | 69.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 9130
- Matched controls
- 91307
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
547.4
323.0
1670
37
130
Kela drug reimbursment
Malignant tumour
21.3
323.0
4447
3905
B01AB05
ATC
enoxaparin; parenteral
4.1
323.0
4832
19599
A04AA02
ATC
granisetron; systemic, transdermal
11.9
323.0
2110
2252
L01BC06
ATC
capecitabine; oral
86.9
323.0
3435
630
H02AB02
ATC
dexamethasone; systemic
6.1
323.0
2354
4915
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
16.3
323.0
871
586
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
352.1
323.0
440
13
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
251.2
323.0
1220
56
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.7
323.0
953
1569
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
389.0
323.0
3160
124
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
78.6
323.0
719
99
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
353.4
323.0
409
12
WF001
NOMESCO Finland
Preoperative radiotherapy
115.9
323.0
842
80
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.0
323.0
1335
1917
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
200.2
323.0
1763
109
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
251.9
323.0
363
15
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
178.8
323.0
507
30
Z93.3
ICD-10 Finland
Colostomy status
59.4
323.0
553
99
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.3
323.0
1497
1559
JN4AD
NOMESCO Finland
Body CT examination
5.8
323.0
1850
3815
JG1BG
NOMESCO Finland
MRI of rectum
136.3
323.0
611
48
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
11.1
323.0
1301
1349
TJF80
NOMESCO Finland
Ostomy education
30.5
323.0
566
197
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
434.6
323.0
908
23
D75
ICPC
Malignant neoplasm colon/rectum
145.9
323.0
676
50
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.7
323.0
936
1329
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
312.3
323.0
663
23
JFF23
NOMESCO Finland
Transversostomy
63.3
323.0
851
148
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
16.3
323.0
925
628
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.7
323.0
808
1130
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
16384.0
323.0
1427
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
216.6
323.0
607
30
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
857.3
323.0
488
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
13.7
323.0
654
510
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
323.0
423
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
323.0
3716
18596
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
9.1
323.0
903
1083
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
150.2
323.0
484
34
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
2962.1
323.0
2890
13
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
293.8
323.0
392
14
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
323.0
1956
5546
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
323.0
3711
15516
JFB30
NOMESCO Finland
Right hemicolectomy
66.3
323.0
1221
212
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
306.1
323.0
598
21
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
172.2
323.0
773
49
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
24.2
323.0
811
367
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
11.7
323.0
2995
3655
UJF32
NOMESCO Finland
Coloscopy
9.9
323.0
6142
15709
JG1CG
NOMESCO Finland
Extensive MRI of rectum
110.6
323.0
482
46
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
488.9
323.0
377
8
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
2770.0
323.0
543
*
WZC30
NOMESCO Finland
Teaching
4.2
323.0
2289
6738
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
2339.5
323.0
683
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
1504.3
323.0
819
6
A03FA01
ATC
metoclopramide; systemic, rectal
6.4
323.0
4286
11032
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
3507.4
323.0
348
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
33.8
323.0
527
165
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
862.3
323.0
333
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
19.3
323.0
1108
649
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.3
323.0
1815
2646
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
94.0
323.0
1114
135
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.4
323.0
888
1308
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
323.0
768
*
JN4BD
NOMESCO Finland
Extensive body CT
7.7
323.0
3161
5847
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.4
323.0
2277
1807
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
206.6
323.0
741
39
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
443.5
323.0
1032
26
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
365.3
318.8
320
9
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.0
311.0
1084
2377
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
307.7
1654
5417
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
250.0
306.8
314
13
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
768.3
303.9
298
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
191.8
302.7
315
17
B01AB10
ATC
tinzaparin; parenteral
4.3
296.8
1231
3214
JFB46
NOMESCO Finland
Resection of sigmoid colon
15.8
289.6
487
324
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
288.9
922
1822
UJG02
NOMESCO Finland
Proctoscopy
9.4
287.6
623
705
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
362.0
281.7
283
8
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.8
280.8
517
425
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
17.0
280.6
458
282
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
348.6
271.3
273
8
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
96.6
270.0
299
32
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
265.1
675
988
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
339.2
264.0
266
8
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
1315.5
263.6
256
*
JFB43
NOMESCO Finland
Left hemicolectomy
28.8
259.8
358
129
JFF10
NOMESCO Finland
Loop enterostomy
40.3
259.3
330
85
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
47.5
257.6
317
69
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
72.1
255.9
294
42
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
327.0
249.4
252
8
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
5.2
245.7
816
1677
WX600
NOMESCO Finland
Single shot through catheter
15.8
242.2
407
269
WX402
NOMESCO Finland
General anaesthesia
2.8
241.2
1819
7422
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
96.3
236.6
262
28
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
344.5
235.3
237
7
Z51.5
ICD-10 Finland
Palliative care
3.7
234.8
1126
3306
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
8.5
228.8
525
651
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
566.7
224.4
222
*
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
46.6
223.5
276
61
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
15.1
223.2
382
264
L01BC59
ATC
trifluridine, combinations; systemic
1109.9
222.7
217
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.3
216.7
711
1435
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
1068.0
214.3
209
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
1052.3
211.2
206
*
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
220.1
208.4
215
10
N02AA05
ATC
oxycodone; systemic
2.4
200.4
2001
9450
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
102.5
200.0
220
22
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
337.7
198.4
200
6
JAH00
NOMESCO Finland
Laparotomy
6.0
197.2
577
1012
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
193.4
940
2768
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
6.4
190.4
527
859
ZX120
NOMESCO Finland
Intravenous
3.0
189.7
1267
4714
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
246.3
188.3
193
8
369
Kela drug reimbursment
Regorafenib
166.0
185.4
195
12
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
183.9
176
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
239.8
183.2
188
8
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
459.2
181.7
181
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
117.2
179.8
195
17
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
179.2
1084
3761
A04AA01
ATC
ondansetron; systemic, rectal
3.5
177.8
931
2902
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
+∞
176.6
169
*
176
Kela drug reimbursment
Regorafenib
120.6
174.8
189
16
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
224.2
170.8
176
8
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
345.5
169.8
171
5
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.1
169.8
710
1826
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
168.5
1310
5330
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.1
166.7
364
413
SPAT1125
SPAT
Stoma care and guidance
7.4
165.8
415
586
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
162.1
1004
3524
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
239.9
160.8
165
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
159.1
2281
12553
1XC07
NOMESCO Finland
NA
69.0
158.5
183
27
C18
ICD-10 Finland
Malignant neoplasm of colon
530.3
158.3
157
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
12.5
157.4
291
239
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
229.6
153.6
158
7
N02BE01
ATC
paracetamol; systemic, rectal
2.1
151.2
7766
66698
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.6
149.6
403
631
JFB00
NOMESCO Finland
Partial resection of small intestine
6.9
145.3
382
578
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.7
144.1
675
1911
JJB10
NOMESCO Finland
Atypcal resection of liver
54.7
143.7
172
32
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
+∞
141.0
135
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
141.0
1081
4330
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
+∞
137.8
132
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
15.0
136.6
233
159
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
35.6
136.5
178
51
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.9
128.6
243
209
K56.7
ICD-10 Finland
Ileus, unspecified
6.1
128.5
366
616
Z93
ICD-10 Finland
Artificial opening status
37.5
125.8
162
44
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
20.0
125.4
192
98
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
124.6
756
2598
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.2
121.5
706
2350
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
76.8
119.6
136
18
L01XE21
ATC
[U] regorafenib; oral
140.8
117.4
125
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
115.7
1149
5260
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.0
115.0
494
1292
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
570.1
114.2
113
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
26.9
113.9
159
60
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.6
112.5
542
1563
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
+∞
111.7
107
*
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
169.2
111.5
117
7
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
110.8
1305
6471
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
21.3
108.8
163
78
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
279.5
108.1
110
*
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
1040.3
105.5
103
*
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
5.8
103.2
308
549
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.4
102.9
399
947
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
+∞
102.3
98
*
E0000UV
ATC
NA
1.7
102.2
3316
23333
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
101.9
431
1110
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
+∞
101.2
97
*
JAH01
NOMESCO Finland
Laparoscopy
3.7
100.2
474
1344
A04AD12
ATC
aprepitant; systemic
5.4
99.9
316
604
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
76.4
99.4
113
15
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
12.5
99.0
182
148
JGB36
NOMESCO Finland
Wide excision of rectum
173.5
98.4
103
6
WW500
NOMESCO Finland
Blood transfusion
3.2
97.1
544
1759
JFB50
NOMESCO Finland
Other resection of colon
26.4
95.0
133
51
Z43.3
ICD-10 Finland
Attention to colostomy
31.4
94.9
127
41
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
245.0
94.8
97
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
8.1
93.6
218
275
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
40.9
92.8
117
29
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.3
92.7
258
421
WX704
NOMESCO Finland
Intubation
2.6
92.2
741
3015
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
125.1
92.1
99
8
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
887.0
89.9
88
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.4
89.5
473
1463
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
4.0
89.2
374
955
B01AB04
ATC
dalteparin; parenteral
2.8
89.0
620
2316
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
88.2
344
821
JF2AB
NOMESCO Finland
Colongraphy with X-ray
21.4
87.9
131
62
A04AA55
ATC
palonosetron, combinations; systemic
4.3
87.6
340
807
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.7
87.5
261
465
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
86.8
2837
19770
R4110
NOMESCO Finland
Physiotherapy
1.7
86.1
2409
16079
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
31.5
86.0
115
37
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
426.5
85.2
85
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.8
85.0
295
625
A02BC02
ATC
pantoprazole; systemic
1.5
84.0
5677
47045
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
5.0
83.9
285
590
D99
ICPC
Disease digestive system other
7.7
83.8
202
269
1541A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]
287.6
83.7
85
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.9
83.2
242
418
Z43.2
ICD-10 Finland
Attention to ileostomy
50.5
82.7
100
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.6
81.9
656
2657
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.9
81.5
179
205
SPAT1262
SPAT
Handing over of treatment supplies
1.7
81.4
1858
11644
Z31.5
ICD-10 Finland
Genetic counselling
3.7
80.5
373
1038
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
27.8
79.8
110
40
D18
ICPC
Change in faeces/bowel movements
4.3
79.0
305
720
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.1
78.4
321
801
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
78.4
1224
6735
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.7
78.2
278
604
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
+∞
78.2
75
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
77.8
4091
31764
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
11.2
77.1
149
135
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
75.9
1701
10570
JFB40
NOMESCO Finland
Resection of transverse colon
28.4
75.9
104
37
Z93.2
ICD-10 Finland
Ileostomy status
17.7
75.0
119
68
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
32.3
74.6
99
31
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
157.3
74.1
78
5
JG1DG
NOMESCO Finland
Very extensive MRI of rectum
132.8
74.0
79
6
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
20.2
73.9
112
56
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.8
73.2
174
227
C18.6
ICD-10 Finland
Malignant neoplasm: Descending colon
+∞
73.0
70
*
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
365.2
72.8
73
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
72.3
560
2221
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
20.4
72.2
109
54
L01BC53
ATC
tegafur, combinations; systemic
44.9
72.1
89
20
JAL30
NOMESCO Finland
Omentectomy
6.7
71.4
189
289
V03AF03
ATC
calcium folinate; systemic
24.9
71.1
101
41
UJF34
NOMESCO Finland
Left colonoscopy
8.1
71.0
165
208
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
9.5
69.8
147
157
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
344.8
68.6
69
*
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
235.0
68.3
70
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
68.2
427
1485
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
9.9
68.1
140
143
ZXC96
NOMESCO Finland
Robot assisted procedure
3.4
67.8
349
1057
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
61.3
67.6
79
13
K92.1
ICD-10 Finland
Melaena
2.4
67.4
639
2825
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
67.3
819
4063
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
53.1
66.0
79
15
JG1CM
NOMESCO Finland
Extensive MRI of rectum (more than 1.5 T)
117.5
64.9
70
6
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.6
63.2
231
517
JKA20
NOMESCO Finland
Cholecystectomy
3.0
63.1
382
1299
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.6
63.1
296
832
A79
ICPC
Malignancy NOS
4.7
63.0
223
483
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.2
62.9
351
1128
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
622.4
62.9
62
*
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
+∞
62.6
60
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
40.8
61.3
77
19
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
4.6
61.0
222
495
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
34.6
60.7
79
23
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
9.8
59.6
123
127
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
58.9
1556
10057
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
581.8
58.7
58
*
6404
FHL
Hemicolectomy on the right
30.2
58.0
78
26
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
58.0
650
3104
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.5
57.4
280
813
8480/3-C18.7
ICD-O-3
Mucinous adenocarcinoma of sigmoid colon
+∞
57.3
55
*
JFF26
NOMESCO Finland
Sigmoidostomy
24.7
57.1
81
33
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.0
57.0
352
1212
JJB30
NOMESCO Finland
Excision of two segments of liver
42.0
56.9
71
17
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
24.0
56.6
81
34
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
55.6
214
505
6434
FHL
Anterior resection
24.1
55.3
79
33
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
283.2
55.2
56
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.7
55.1
256
715
TPX15
NOMESCO Finland
Removal of vascular injection port
10.9
55.0
107
99
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
5.7
54.9
162
286
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.6
54.3
163
294
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.4
54.2
278
839
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
54.2
588
2764
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
36.6
53.8
69
19
JFF13
NOMESCO Finland
Terminal enterostomy
19.9
53.4
81
41
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
53.3
519
2319
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
75.6
53.0
60
8
JGB20
NOMESCO Finland
Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis
84.9
52.9
59
7
JEA00
NOMESCO Finland
Appendectomy
2.3
52.6
508
2259
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
52.2
2547
18981
R4190
NOMESCO Finland
Nutritional therapy
3.1
52.2
299
979
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
51.5
184
403
JFB20
NOMESCO Finland
Ileocaecal resection
8.8
51.4
112
128
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
17.4
51.0
81
47
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
36.3
50.6
65
18
C18.81
ICD-10 Finland
Malignant overall tumor of the colon invasive carcinoma
490.5
49.4
49
*
JFF24
NOMESCO Finland
Laparoscopic transversostomy
39.0
49.1
62
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
49.0
1156
7197
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
48.9
304
1051
C21.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal
53.0
48.6
58
11
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
+∞
47.9
46
*
D77
ICPC
Malignant digestive neopl other/NOS
9.7
47.9
99
103
8480/3-C18.4
ICD-O-3
Mucinous adenocarcinoma of transverse colon
+∞
46.9
45
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
4.1
46.9
189
467
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
12.4
46.7
85
69
1XC08
NOMESCO Finland
NA
460.1
46.3
46
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
46.3
420
1812
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
16.9
46.2
74
44
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
13.4
46.0
81
61
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.4
45.9
412
1767
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
+∞
44.8
43
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.0
44.8
147
295
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
7.3
44.7
110
153
WX110
NOMESCO Finland
Local anesthesy
1.4
44.6
5059
43500
JJB20
NOMESCO Finland
Excision of single segment of liver
45.2
44.1
54
12
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
+∞
43.8
42
*
S18
ICPC
Laceration/cut
1.4
42.8
3546
28875
WF004
NOMESCO Finland
Palliative radiotherapy
3.1
42.5
246
813
6435
FHL
Abdominoperineal resection and colostomy
78.8
41.9
47
6
C18.80
ICD-10 Finland
Malignant overall tumor of the colon without histology
147.3
41.8
44
*
K65.0
ICD-10 Finland
Acute peritonitis
4.2
41.6
165
402
R50.9
ICD-10 Finland
Fever, unspecified
1.6
41.4
1144
7416
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.7
41.2
143
305
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
40.7
686
3833
JFA42
NOMESCO Finland
Endoscopic injection in colon
9.2
40.6
86
94
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
26.8
40.6
56
21
SPAT1153
SPAT
Removal of sutures
1.4
40.6
2738
21473
P01AB01
ATC
metronidazole; oral, rectal
1.4
40.5
2836
22381
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.8
40.3
266
959
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
13.6
40.1
70
52
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
13.0
39.9
71
55
JG001
NOMESCO Finland
Preopertaive radiotherapy of rectum
200.8
38.8
40
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.2
38.8
212
673
1534A
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]
+∞
38.6
37
*
1533A
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]
+∞
38.6
37
*
JFC10
NOMESCO Finland
Ileotransversostomy
33.5
38.4
50
15
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.9
38.1
163
426
JGB11
NOMESCO Finland
Laparoscopic partial proctectomy and end colostomy
195.8
37.8
39
*
ZX121
NOMESCO Finland
Central venous catheter
9.8
37.7
77
79
WX002
NOMESCO Finland
Sedation and analgesia
1.5
37.6
1662
11999
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
26.1
37.5
52
20
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
+∞
37.5
36
*
K56.0
ICD-10 Finland
Paralytic ileus
4.3
37.5
144
341
WX882
NOMESCO Finland
High dependency care
2.6
37.2
277
1074
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
37.2
674
3856
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
61.7
37.1
43
7
8070/3-C20.9
ICD-O-3
Squamous cell carcinoma, NOS, of rectum, NOS
+∞
36.5
35
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
5.5
36.4
110
202
D16
ICPC
Rectal bleeding
3.0
36.0
213
713
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.5
36.0
132
299
C209
ICD-10 Finland
NA
358.7
36.0
36
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
7.6
35.7
85
113
TJG20
NOMESCO Finland
Transanal irrigation
15.2
35.6
59
39
8000/3-C20.9
ICD-O-3
Neoplasm, malignant of rectum, NOS
+∞
35.4
34
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
34.7
2001
15172
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
10.2
34.6
69
68
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
6.5
34.4
91
141
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
15.4
33.3
55
36
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.0
33.2
93
156
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
10.4
32.9
65
63
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
6.8
32.8
84
125
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
30.8
32.5
43
14
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
32.5
509
2766
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
6.1
32.3
89
146
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
18.9
32.1
49
26
J01MA12
ATC
levofloxacin; systemic
1.4
32.1
1624
11996
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
61.9
32.0
37
6
JEA01
NOMESCO Finland
Laparoscopic appendectomy
2.8
31.8
215
787
JFF30
NOMESCO Finland
Other colostomy
16.0
31.5
51
32
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
8.8
31.4
68
78
XJG12
NOMESCO Finland
Transrectal endoscopic ultrasonography
16.2
31.0
50
31
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
31.0
651
3894
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
6.9
30.6
77
112
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
12.3
30.4
55
45
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
+∞
30.2
29
*
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
3.8
30.0
131
350
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.7
30.0
65
75
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.4
30.0
254
1058
R11
ICD-10 Finland
Nausea and vomiting
1.7
30.0
616
3661
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
29.9
633
3794
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
32.6
29.9
39
12
L03AA02
ATC
filgrastim; parenteral
2.4
29.7
259
1097
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.9
29.1
97
200
SPAT1131
SPAT
Colonoscopy
2.2
28.9
305
1415
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
28.0
28.8
39
14
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
28.6
532
3066
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
17.7
28.2
44
25
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
39.1
28.0
35
9
3AC01
NOMESCO Finland
NA
3.8
27.7
119
314
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.9
27.3
114
294
8000/3-C18.9
ICD-O-3
Neoplasm, malignant of colon, NOS
+∞
27.1
26
*
A06AH03
ATC
naloxegol; oral
3.4
27.0
132
388
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
140.4
26.6
28
*
N03AX16
ATC
pregabalin; oral
1.4
26.6
1775
13712
WF002
NOMESCO Finland
Radical radiotherapy
1.8
26.3
464
2626
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
51.8
26.2
31
6
Z51.0
ICD-10 Finland
Radiotherapy session
3.1
26.0
143
459
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
25.8
761
4988
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
25.3
1286
9465
B80
ICPC
Iron deficiency anaemia
2.8
25.2
171
628
LCD00
NOMESCO Finland
Hysterectomy
2.1
25.2
302
1482
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
8.5
25.2
55
65
JFH10
NOMESCO Finland
Total colectomy and ileostomy
9.3
25.1
52
56
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
25.0
24
*
KCD10
NOMESCO Finland
Partial cystectomy
17.0
24.8
39
23
JG1BM
NOMESCO Finland
MRI of rectum (more than 1.5 T)
250.8
24.7
25
*
15411
ICD-8 Finland
Malignant neoplasm of rectum and rectosigmoid junction, Rectum
250.8
24.7
25
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.1
24.7
291
1418
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
5.8
24.2
69
120
JMA10
NOMESCO Finland
Transabdominal total splenectomy
5.0
24.0
78
158
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
+∞
24.0
23
*
1536A
ICD-9 Finland
Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]
+∞
24.0
23
*
D48.42
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum originating in the appendix
67.6
23.8
27
*
1541X
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]
240.5
23.6
24
*
K43.5
ICD-10 Finland
Parastomal hernia without obstruction or gangrene
33.4
23.3
30
9
L01EX05
ATC
regorafenib; oral
46.8
23.3
28
6
JJA20
NOMESCO Finland
Open biopsy of liver
7.8
23.1
53
68
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.2
23.0
122
383
JFC20
NOMESCO Finland
Other enterocolostomy
22.1
22.9
33
15
SPAT1109
SPAT
Analgesia with portable analgesic pump
4.3
22.7
84
195
R18
ICD-10 Finland
Ascites
2.5
22.7
175
696
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
3.8
22.6
97
258
XQ902
NOMESCO Finland
Other photography
5.2
22.5
70
135
L03AA13
ATC
pegfilgrastim; parenteral
2.0
22.3
285
1437
N02AX02
ATC
tramadol; systemic, rectal
1.3
22.2
3382
29138
L01BC04
ATC
carmofur; oral
16.7
22.2
35
21
A06AD11
ATC
lactulose; oral
1.4
22.0
1334
10108
JAD10
NOMESCO Finland
Repair of incisional hernia
3.7
22.0
98
269
C18.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of colon
+∞
21.9
21
*
8210/3-C20.9
ICD-O-3
Adenocarcinoma in adenomatous polyp of rectum, NOS
+∞
21.9
21
*
C18.82
ICD-10 Finland
Malignant overall tumor of colon carcinoma of adenoma
+∞
21.9
21
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.2
21.8
118
377
WX892
NOMESCO Finland
Monitored bed care
1.6
21.7
624
4058
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
4.5
21.5
76
169
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
5.6
21.5
63
114
Z71.8
ICD-10 Finland
Other specified counselling
1.3
21.3
1489
11538
LEC00
NOMESCO Finland
Partial excision of vagina
17.4
21.3
33
19
R03AC02
ATC
salbutamol; inhalant
0.8
20.9
2826
32797
8210/3-C18.7
ICD-O-3
Adenocarcinoma in adenomatous polyp of sigmoid colon
+∞
20.8
20
*
8144/3-C20.9
ICD-O-3
Adenocarcinoma, intestinal type of rectum, NOS
+∞
20.8
20
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.9
20.8
126
433
D28
ICPC
Limited function/disability (D)
6.3
20.7
55
88
C18.89
ICD-10 Finland
Malignant overall tumor of the colon other or unspecified histology
76.9
20.7
23
*
JFA68
NOMESCO Finland
Endoscopic insertion of prosthetic tube into colon
210.4
20.6
21
*
K62.1
ICD-10 Finland
Rectal polyp
3.2
20.4
107
334
JFH96
NOMESCO Finland
Other total colectomy
25.5
20.4
28
11
WGA11
NOMESCO Finland
Planning of pain management
10.9
20.1
38
35
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
1.7
19.9
382
2223
8244/3-C18.1
ICD-O-3
Mixed adenoneuroendocrine carcinoma of appendix
+∞
19.8
19
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
8.8
19.8
42
48
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.4
19.6
171
725
QX9VV
NOMESCO Finland
NA
29.0
19.6
26
9
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
200.4
19.6
20
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
5.8
19.5
55
95
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
8.9
19.5
41
46
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
19.5
1073
7984
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
10.0
19.3
38
38
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
9.1
19.3
40
44
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
3.4
19.2
93
274
LAE10
NOMESCO Finland
Unilateral oophorectomy
6.9
19.1
47
68
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
20.1
19.0
28
14
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.1
19.0
46
65
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
34.4
18.9
24
7
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
18.5
268
1421
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
3.5
18.5
86
246
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
18.5
183
828
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.6
18.4
139
549
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
18.3
305
1694
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.3
18.2
93
286
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
17.5
18.2
28
16
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
14.3
18.0
30
21
NET99
NOMESCO Finland
Other operation on pelvis
32.9
17.9
23
7
E34.0
ICD-10 Finland
Carcinoid syndrome
6.5
17.9
46
71
GDB10
NOMESCO Finland
Wedge resection of lung
8.3
17.9
39
47
3049
Kela drug reimbursment
NA
+∞
17.7
17
*
15302
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Cacci
180.3
17.5
18
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
17.3
774
5541
ZX100
NOMESCO Finland
Oral
2.6
17.3
131
518
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
5.7
17.1
49
87
JFA70
NOMESCO Finland
Suture of small intestine
5.7
17.1
49
87
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
17.0
1072
13681
JFB96
NOMESCO Finland
Other partial excision of intestine
15.9
17.0
27
17
JFW98
NOMESCO Finland
Other transluminal endoscopic operation on intestine
50.1
17.0
20
*
JHA00
NOMESCO Finland
Anal or perianal incision
3.0
16.9
98
329
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
16.9
361
2170
K63.5
ICD-10 Finland
Polyp of colon
2.8
16.8
109
394
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
16.8
268
1471
K91.3
ICD-10 Finland
Postoperative intestinal obstruction
14.0
16.7
28
20
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
4.3
16.7
62
146
8240/3-C18.0
ICD-O-3
Neuroendocrine tumor, NOS, of cecum
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
J01MA02
ATC
ciprofloxacin; systemic
1.2
16.5
3162
27672
JJA43
NOMESCO Finland
Destruction of lesion of liver
27.5
16.5
22
8
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
6.0
16.3
44
73
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
11.1
16.2
30
27
A28
ICPC
Limited function/disability NOS
1.3
16.2
1334
10556
D29
ICPC
Digestive symptom/complaint other
2.4
16.1
140
597
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
15.9
1115
8611
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.8
15.8
67
179
1XA03
NOMESCO Finland
NA
60.1
15.7
18
*
K45.0
ICD-10 Finland
Other specified abdominal hernia with obstruction, without gangrene
8.3
15.7
34
41
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
4.3
15.7
58
137
1540A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]
+∞
15.6
15
*
8000/3-C18.7
ICD-O-3
Neoplasm, malignant of sigmoid colon
+∞
15.6
15
*
ZXC40
NOMESCO Finland
Use of ultrasound
3.8
15.6
66
176
UJH02
NOMESCO Finland
Anoscopy
1.8
15.4
289
1671
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
15.2
807
5957
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
15.2
1134
8842
KBH20
NOMESCO Finland
Replantation of ureter
8.3
15.2
33
40
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.3
15.2
142
629
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
17.7
15.1
23
13
NK6LA
NOMESCO Finland
Bone and joint kinetic X-ray examination
9.4
14.9
30
32
M25.5
ICD-10 Finland
Pain in joint
0.8
14.8
1165
14476
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
2.9
14.8
87
298
D50
ICD-10 Finland
Iron deficiency anaemia
2.4
14.6
121
505
8000/3-C18.2
ICD-O-3
Neoplasm, malignant of ascending colon
+∞
14.6
14
*
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
4.2
14.6
54
128
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
5.4
14.6
43
80
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
12.5
14.3
25
20
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.8
14.3
250
1416
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.7
14.3
97
362
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
17.0
14.3
22
13
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.9
14.1
85
296
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
14.1
1030
8002
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.6
14.0
63
178
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
3.7
14.0
60
163
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.1
13.9
158
763
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.1
13.9
153
729
LEE10
NOMESCO Finland
Repair of vagina using graft or flap
53.4
13.8
16
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
13.8
121
519
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.9
13.7
81
279
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
5.4
13.7
40
74
JGA98
NOMESCO Finland
Other transluminal endoscopic local operation on rectum
9.7
13.7
27
28
N05AX08
ATC
risperidone; systemic
0.6
13.6
260
4076
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.5
13.6
105
423
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
7.6
13.6
31
41
JGA58
NOMESCO Finland
Endoscopic insertion of prosthetic tube into rectum
+∞
13.5
13
*
XX1AD
NOMESCO Finland
Other CT-examination
3.3
13.5
66
199
KBV10
NOMESCO Finland
Removal of stent from ureter
3.2
13.5
70
221
ZX080
NOMESCO Finland
Image guided radiotherapy
2.1
13.3
154
751
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
21.1
13.3
19
9
UJF32
SPAT
NA
2.3
13.1
117
507
R19.4
ICD-10 Finland
Change in bowel habit
2.0
13.1
169
862
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
13.1
35
58
KA1FN
NOMESCO Finland
Isotope renography
3.4
13.1
63
188
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
5.4
13.1
38
70
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
4.8
13.0
42
87
6406
FHL
Other column resection
7.1
13.0
31
44
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
5.2
12.9
39
75
D17
ICPC
Incontinence of bowel
3.0
12.9
74
248
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
12.9
1279
15503
WW200
SPAT
NA
0.6
12.9
278
4245
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
12.9
450
3064
SPAT1255
SPAT
Intravenous administration of medicine
1.5
12.8
493
3422
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
3.2
12.8
67
213
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.2
12.8
9
552
JFG29
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to rectum
11.5
12.8
23
20
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.7
12.7
86
323
JWC00
NOMESCO Finland
Reoperation for deep infection in gastroenterological surgery
8.5
12.7
27
32
K43.3
ICD-10 Finland
Parastomal hernia with obstruction, without gangrene
69.9
12.6
14
*
8480/3-C18.8
ICD-O-3
Mucinous adenocarcinoma of overlapping lesion of colon
+∞
12.5
12
*
8480/3-C18.6
ICD-O-3
Mucinous adenocarcinoma of descending colon
+∞
12.5
12
*
B82
ICPC
Anaemia other/unspecified
1.8
12.5
196
1075
JF2BD
NOMESCO Finland
Extensive colon CT
2.7
12.5
84
315
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
3.3
12.5
61
185
K61.1
ICD-10 Finland
Rectal abscess
4.8
12.4
40
83
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.5
12.3
93
370
SPAT1078
SPAT
Removal of central venous or arterial cannula
7.6
12.3
28
37
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
6.8
12.3
30
44
M01AC06
ATC
meloxicam; systemic, rectal
0.8
12.3
1942
22487
R01AD09
ATC
mometasone; nasal
0.8
12.3
2112
24264
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
2.9
12.3
76
268
D64.8
ICD-10 Finland
Other specified anaemias
2.1
12.3
135
647
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.8
12.2
200
1112
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
2.8
12.1
76
272
WX004
NOMESCO Finland
Patient-controlled sedation
3.7
12.1
52
142
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
12.1
1471
17475
WX290
NOMESCO Finland
Other blockade of nerve
1.2
12.0
2315
20117
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
12.0
455
3156
N81.6
ICD-10 Finland
Rectocele
0.6
11.9
151
2597
WX400
NOMESCO Finland
Inhalation anesthesy
1.7
11.8
225
1312
K63.9
ICD-10 Finland
Disease of intestine, unspecified
3.9
11.8
47
121
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
6.1
11.8
31
51
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.6
11.7
86
338
C10AX09
ATC
ezetimibe; oral
0.7
11.7
460
6300
N32.1
ICD-10 Finland
Vesicointestinal fistula
4.6
11.6
39
85
15331
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Sigmoid colon
65.0
11.6
13
*
RD211
NOMESCO Finland
NA
1.6
11.6
292
1842
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
4.7
11.6
38
81
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
11.6
1579
18548
R10.0
ICD-10 Finland
Acute abdomen
1.8
11.6
196
1104
1531A
ICD-9 Finland
Malignant neoplasm of colon, Transverse colon[NEOPL MALIG COLI TRANSV,INVASIIVINEN KARSINOOMA]
+∞
11.5
11
*
15311
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Transverse colon, including hepatic and splenic flexures
120.1
11.4
12
*
L01
ICPC
Neck symptom/complaint
0.7
11.4
458
6255
WX610
NOMESCO Finland
Patient controlled analgesia
3.7
11.4
48
130
D07AA02
ATC
hydrocortisone; topical
1.3
11.3
810
6265
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
6.9
11.3
27
39
JGA96
NOMESCO Finland
Other proctotomy or local operation on rectum
9.6
11.2
22
23
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.8
11.2
1131
13701
M01AH05
ATC
etoricoxib; oral
0.9
11.1
3268
36008
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.7
11.1
72
265
Z93.4
ICD-10 Finland
Other artificial openings of gastrointestinal tract status
12.7
11.1
19
15
JFB41
NOMESCO Finland
Laparoscopic resection of transverse colon
20.0
11.1
16
8
M01AB05
ATC
diclofenac; systemic, rectal
0.9
11.0
4174
45135
JFC00
NOMESCO Finland
Entero-enterostomy
6.1
11.0
29
48
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.1
11.0
114
535
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
5.8
11.0
30
52
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.8
11.0
192
1093
E86
ICD-10 Finland
Volume depletion
1.8
10.9
196
1125
GDB20
NOMESCO Finland
Segmental resection of lung
13.9
10.9
18
13
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
2.7
10.9
70
256
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
6.6
10.9
27
41
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
43.3
10.9
13
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.0
10.9
142
729
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
5.9
10.8
29
49
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
10.8
1394
16482
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
10.8
102
460
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.3
10.7
96
421
R05FB02
ATC
cough suppressants and expectorants
0.8
10.7
2287
25855
ZX050
NOMESCO Finland
Stereotactic radiotherapy
2.8
10.7
67
241
JJA40
NOMESCO Finland
Excision of lesion of liver
21.5
10.7
15
7
JFF31
NOMESCO Finland
Other laparoscopic colostomy
60.0
10.6
12
*
JF2CG
NOMESCO Finland
Extensive MRI of colon
60.0
10.6
12
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
10.6
490
3531
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.2
10.5
107
495
WGA10
NOMESCO Finland
Measurement of pain intensity
11.2
10.5
19
17
UKC02
NOMESCO Finland
Cystoscopy
1.2
10.5
1408
11786
Z93.8
ICD-10 Finland
Other artificial opening status
14.2
10.5
17
12
M48.0
ICD-10 Finland
Spinal stenosis
0.8
10.5
602
7808
15301
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Appendicis
110.1
10.4
11
*
8480/3-C18.5
ICD-O-3
Mucinous adenocarcinoma of splenic flexure of colon
+∞
10.4
10
*
8010/3-C20.9
ICD-O-3
Carcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
8249/3-C18.0
ICD-O-3
Neuroendocrine tumor, grade 2 of cecum
+∞
10.4
10
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.4
10.4
85
357
ZSJ00
NOMESCO Finland
Procedure related to previous procedure classified in chapter J
6.8
10.3
25
37
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
16.0
10.3
16
10
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.2
10.3
103
473
N06CA01
ATC
amitriptyline and psycholeptics; systemic
0.7
10.3
376
5214
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
6.4
10.3
26
41
R52.0
ICD-10 Finland
Acute pain
1.8
10.3
169
943
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
10.3
463
3321
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.0
10.3
124
618
C187, 8211, 2
ICD-O-3
NA
18.8
10.2
15
8
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
1.8
10.2
163
900
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
7.4
10.1
23
31
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
10.1
696
8823
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
2.4
10.1
80
331
G04CA02
ATC
tamsulosin; oral
1.2
10.1
2213
19414
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
14.6
10.0
16
11
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
3.5
10.0
45
130
KCH00
NOMESCO Finland
Suture of bladder
5.1
10.0
30
59
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.2
9.9
1328
11107
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
9.9
1176
9705
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
2.9
9.9
57
195
TJA10
NOMESCO Finland
Laparocentesis
4.5
9.8
33
73
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
9.8
1612
18654
K63.0
ICD-10 Finland
Abscess of intestine
7.0
9.8
23
33
M01AE02
ATC
naproxen; oral, rectal
0.9
9.7
3212
35197
L08
ICPC
Shoulder symptom/complaint
0.8
9.7
867
10656
A41.9
ICD-10 Finland
Sepsis, unspecified
1.5
9.7
278
1817
JAG96
NOMESCO Finland
Other reconstruction of abdominal wall
6.5
9.7
24
37
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.7
9.6
321
4519
JF1BD
NOMESCO Finland
Very extensive small bowel CT
3.1
9.6
50
161
G47.3
ICD-10 Finland
Sleep apnoea
0.8
9.5
971
11764
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
4.6
9.5
31
67
KCC10
NOMESCO Finland
Cystoprostatectomy
3.0
9.5
52
174
N06AA09
ATC
amitriptyline; systemic
0.7
9.4
394
5348
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.4
9.4
78
330
L15
ICPC
Knee symptom/complaint
0.8
9.4
956
11591
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.4
9.4
78
331
8490/3-C18.0
ICD-O-3
Signet ring cell carcinoma of cecum
+∞
9.4
9
*
8490/3-C20.9
ICD-O-3
Signet ring cell carcinoma of rectum, NOS
+∞
9.4
9
*
1533X
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,EI HISTOLOGISTA VAHVISTUSTA]
+∞
9.4
9
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
9.4
287
4099
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
9.4
319
2166
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
9.3
420
5636
A07DA03
ATC
loperamide; oral
1.5
9.3
266
1737
XF622
NOMESCO Finland
Measurement of minute volume of heart
3.8
9.3
37
97
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.7
9.3
345
4768
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
4.8
9.2
29
60
K63.2
ICD-10 Finland
Fistula of intestine
5.7
9.2
25
44
JFA86
NOMESCO Finland
Closure of fistula of colon
13.7
9.2
15
11
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.7
9.1
170
988
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.6
9.1
256
1664
JFA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in colon
7.7
9.1
20
26
D74
ICPC
Malignant neoplasm stomach
6.7
9.1
22
33
KA3EB
NOMESCO Finland
Antegrade pyelography
3.0
9.1
50
168
XX_20
NOMESCO Finland
Bioimpedance measurement
8.3
9.0
19
23
JHA10
NOMESCO Finland
Biopsy of anal canal
5.9
9.0
24
41
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
2.4
9.0
75
318
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
9.0
1156
9621
M02AA07
ATC
piroxicam; topical
0.9
8.9
2258
25267
J01DB01
ATC
cefalexin; oral
1.2
8.9
6252
59634
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
12.5
8.8
15
12
SPAT1088
SPAT
Blood transfusion
2.9
8.8
52
182
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
6.8
8.8
21
31
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
4.9
8.8
27
55
K60.4
ICD-10 Finland
Rectal fistula
5.6
8.7
24
43
UKB02
NOMESCO Finland
Retrograde ureteroscopy
2.2
8.7
82
371
H03AA01
ATC
levothyroxine sodium; systemic
0.8
8.7
1093
12975
1534X
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,EI HISTOLOGISTA VAHVISTUSTA]
50.0
8.7
10
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
8.6
961
11549
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
7.6
8.6
19
25
WX250
NOMESCO Finland
Intercostal blockade
5.0
8.6
26
52
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.3
8.6
23
671
JAH33
NOMESCO Finland
Opening of laparostomy
5.2
8.6
25
48
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
5.5
8.6
24
44
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
3.9
8.5
33
85
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.2
8.5
1347
11451
H01CB03
ATC
lanreotide; parenteral
4.0
8.4
32
81
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
3.6
8.4
36
101
JAL00
NOMESCO Finland
Biopsy of peritoneum
3.3
8.4
40
122
M03BX02
ATC
tizanidine; oral
0.9
8.3
3439
37253
8000/3-C18.0
ICD-O-3
Neoplasm, malignant of cecum
+∞
8.3
8
*
1535C
ICD-9 Finland
Malignant neoplasm of colon, Appendix[NEOPL MALIG APPEND VERMIF,MUU TAI MÄÄRITTELEMÄTÖN H]
+∞
8.3
8
*
1532A
ICD-9 Finland
Malignant neoplasm of colon, Descending colon[NEOPL MALIG COLI DESCEND,INVASIIVINEN KARSINOOMA]
+∞
8.3
8
*
8144/3-C18.7
ICD-O-3
Adenocarcinoma, intestinal type of sigmoid colon
+∞
8.3
8
*
15303
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Coli ascendentis
+∞
8.3
8
*
JG003
NOMESCO Finland
Adjuvant radiotherapy of rectum
+∞
8.3
8
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
1.8
8.3
137
768
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
3.5
8.3
37
107
H01CB02
ATC
octreotide; parenteral
3.6
8.3
35
97
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.8
8.3
33
87
JAG00
NOMESCO Finland
Repair of other hernia
6.2
8.3
21
34
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
8.2
469
6089
JFA83
NOMESCO Finland
Excision of lesion of colon
14.5
8.2
13
9
UJK02
NOMESCO Finland
ERCP
1.6
8.2
182
1119
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.7
8.2
163
973
N06AB04
ATC
citalopram; systemic
0.8
8.2
993
11830
M03BC51
ATC
orphenadrine, combinations; systemic
0.8
8.1
1246
14528
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
2.6
8.1
57
224
JFA76
NOMESCO Finland
Closure of fistula of small intestine
11.7
8.1
14
12
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
6.8
8.0
19
28
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.8
8.0
121
660
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
0.7
8.0
186
2793
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.8
8.0
490
6301
D06BX01
ATC
metronidazole; topical
1.3
8.0
587
4561
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.5
8.0
79
1445
R19.5
ICD-10 Finland
Other faecal abnormalities
2.1
8.0
89
434
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
5.2
8.0
23
44
R83
ICPC
Respiratory infection other
0.8
7.9
622
7761
C10AA07
ATC
rosuvastatin; oral
0.8
7.9
1337
15465
R07.4
ICD-10 Finland
Chest pain, unspecified
0.8
7.9
1561
17829
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.7
7.9
384
5094
SPAT1053
SPAT
Memory test
0.8
7.9
974
11585
M01AX05
ATC
glucosamine; oral
0.8
7.8
1182
13809
M54.5
ICD-10 Finland
Low back pain
0.9
7.8
1571
17923
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
6.1
7.8
20
33
E87.6
ICD-10 Finland
Hypokalaemia
1.6
7.8
199
1265
L13
ICPC
Hip symptom/complaint
0.8
7.8
751
9162
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
4.6
7.8
25
54
GD1AD
NOMESCO Finland
Thorax CT examination
1.5
7.8
289
2003
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.1
7.7
28
68
B03BA03
ATC
hydroxocobalamin; parenteral
1.4
7.7
447
3352
6407
FHL
Colectomy and ileorectostomy
15.0
7.7
12
8
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
0.8
7.7
836
10077
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
7.7
396
2917
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.3
7.6
15
504
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
4.7
7.6
24
51
L03
ICPC
Low back symptom/complaint
0.8
7.6
1096
12857
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
2.2
7.6
72
329
C21.2
ICD-10 Finland
Malignant neoplasm: Cloacogenic zone
25.0
7.6
10
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.7
7.5
255
3567
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
7.4
658
8103
WX872
NOMESCO Finland
Intensive care
1.4
7.4
357
2598
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
3.6
7.4
31
86
SPAT1254
SPAT
Administration of medicine
1.2
7.4
1057
8886
R06AX27
ATC
desloratadine; oral
0.8
7.4
963
11407
R33
ICD-10 Finland
Retention of urine
1.3
7.4
668
5337
JFA73
NOMESCO Finland
Excision of lesion of small intestine
5.6
7.3
20
36
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
3.6
7.3
31
87
SAA02
NOMESCO Finland
Basic examination of mouth
0.9
7.3
3399
36649
8010/3-C18.4
ICD-O-3
Carcinoma, NOS, of transverse colon
+∞
7.3
7
*
8010/3-C18.9
ICD-O-3
Carcinoma, NOS, of colon, NOS
+∞
7.3
7
*
8246/3-C18.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of appendix
+∞
7.3
7
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.7
7.3
47
175
JFC30
NOMESCO Finland
Colo-colostomy
10.8
7.3
13
12
M79.6
ICD-10 Finland
Pain in limb
0.9
7.3
1904
21313
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
0.8
7.2
379
4977
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
0.7
7.2
344
4575
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
2.8
7.2
44
160
SPAT1076
SPAT
Cannulation of central vein
6.2
7.2
18
29
J01FA10
ATC
azithromycin; systemic
0.9
7.2
2978
32350
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.7
7.2
138
815
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.8
7.2
585
7271
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
7.2
545
6824
JGB97
NOMESCO Finland
Other laparoscopic proctectomy or excision of rectum
30.0
7.1
9
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.7
7.1
236
3321
JJA23
NOMESCO Finland
Open needle biopsy of liver
20.0
7.1
10
5
K63.8
ICD-10 Finland
Other specified diseases of intestine
4.4
7.1
24
55
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
1.8
7.1
111
615
JGA60
NOMESCO Finland
Suture of rectum
12.0
7.1
12
10
R42
ICD-10 Finland
Dizziness and giddiness
0.8
7.0
1239
14299
L02
ICPC
Back symptom/complaint
0.7
7.0
252
3499
B02AA02
ATC
tranexamic acid; systemic
1.3
7.0
687
5543
D01
ICPC
Abdominal pain/cramps general
1.3
7.0
539
4220
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
2.4
7.0
53
218
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
2.6
7.0
47
182
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.3
7.0
11
416
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
0.7
6.9
153
2316
JF1AD
NOMESCO Finland
Small bowel CT
2.8
6.9
42
153
N05AH04
ATC
quetiapine; oral
0.8
6.9
569
7060
KBD00
NOMESCO Finland
Partial excision of ureter
7.5
6.9
15
20
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
7.5
6.9
15
20
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
0.7
6.9
211
3004
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
13.8
6.9
11
8
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.7
6.9
304
4087
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.8
45
171
J01FA06
ATC
roxithromycin; oral
0.9
6.8
2339
25726
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.7
6.8
279
3792
KC1GD
NOMESCO Finland
CT cystography of bladder
10.9
6.8
12
11
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
9.3
6.8
13
14
J45
ICD-10 Finland
Asthma
0.7
6.8
319
4245
SPAT1138
SPAT
Guidance concerning bowel function
1.8
6.7
106
590
R03BA08
ATC
ciclesonide; inhalant
0.7
6.7
253
3483
L17
ICPC
Foot/toe symptom/complaint
0.9
6.7
1302
14906
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.7
6.7
199
2848
A04AD14
ATC
rolapitant; oral
22.5
6.7
9
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
7.8
6.6
14
18
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.8
6.6
435
5539
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
3.4
6.6
29
85
D82
ICPC
Teeth/gum disease
0.9
6.6
1476
16722
ZXD08
NOMESCO Finland
NA
3.5
6.6
28
80
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
1.8
6.5
101
560
M03BC01
ATC
orphenadrine (citrate); systemic
0.8
6.5
902
10633
J01FA09
ATC
clarithromycin; systemic
0.9
6.5
1465
16597
C209, 8148, 2
ICD-O-3
NA
8.7
6.5
13
15
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.8
6.5
437
5558
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
2.7
6.5
42
157
6405
FHL
Hemicolectomy on the left
5.0
6.5
19
38
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
1.6
6.5
141
865
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.9
6.4
1690
18934
C21
ICD-10 Finland
Malignant neoplasm of anus and anal canal
69.9
6.4
7
*
JWF01
NOMESCO Finland
Percutaneous endoscopic reoperation for insufficiency of anastomosis or suture in gastroenterological
69.9
6.4
7
*
XF612
NOMESCO Finland
Measurement of central venous pressure
3.4
6.4
28
82
D11
ICPC
Diarrhoea
1.3
6.4
491
3848
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
0.8
6.3
472
5923
R01AD08
ATC
fluticasone; nasal
0.9
6.3
1250
14303
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.9
6.3
1672
18725
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.7
6.3
204
2880
L86
ICPC
Back syndrome with radiating pain
0.7
6.3
168
2455
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
6.5
6.3
15
23
R03BA02
ATC
budesonide; inhalant
0.8
6.3
760
9071
QB3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in abdomen
9.2
6.3
12
13
SDA02
NOMESCO Finland
Parodonthologic therapy
0.9
6.3
1511
17036
JJB00
NOMESCO Finland
Wedge resection of liver
18.0
6.3
9
5
1CB02
NOMESCO Finland
NA
18.0
6.3
9
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.9
6.3
1662
18610
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1.8
6.3
102
575
KEC30
NOMESCO Finland
Removal of seminal vesicle
+∞
6.2
6
*
1541B
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,KARSINOOMA ADENOOMASSA]
+∞
6.2
6
*
15321
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Descending colon
+∞
6.2
6
*
8249/3-C20.9
ICD-O-3
Neuroendocrine tumor, grade 2 of rectum, NOS
+∞
6.2
6
*
15401
ICD-8 Finland
Malignant neoplasm of rectum and rectosigmoid junction, Rectosigmoid junction
+∞
6.2
6
*
3860
NOMESCO Finland
NA
+∞
6.2
6
*
N05AA02
ATC
levomepromazine; systemic
0.6
6.2
103
1657
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.8
6.2
448
5645
JFA10
NOMESCO Finland
Colotomy
26.7
6.2
8
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
7.0
6.2
14
20
AN1
HP
Coronary angiography
0.8
6.2
718
8600
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
2.0
6.2
69
341
M43.1
ICD-10 Finland
Spondylolisthesis
0.6
6.2
96
1561
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
2.4
6.1
50
213
K83.1
ICD-10 Finland
Obstruction of bile duct
1.8
6.1
93
512
OAB42
SPAT
NA
0.6
6.1
107
1694
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.8
6.1
325
4252
A89
ICPC
Effect prosthetic device
4.0
6.1
22
55
R01AD12
ATC
fluticasone furoate; nasal
0.9
6.1
1115
12830
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
10.0
6.0
11
11
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
0.7
6.0
245
3330
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
2.8
6.0
35
124
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4366
25882
2.23
315.96
2.9
2.6
u/l
55.4
59.3
4.98
4168
23703
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2405
7624
3.85
307.65
2.5
2.1
g/l
0.2
0.2
0.88
2323
7004
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
2157
2848
9.41
307.65
6.0
2.8
u/ml
1493.8
2480.3
0.42
1951
2397
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3864
19810
2.56
307.65
3.1
2.5
—
—
—
0
0
(4035726)
2169
7030
3.67
307.65
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
7070
8046
28.45
307.65
9.5
2.6
ug/l
32.7
23.3
0.87
6510
6464
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
1129
1684
7.44
307.65
5.5
2.7
u/ml
154.4
801.4
2.95
1026
1533
(3022145) Colonoscopy Study observation
3572
8090
6.35
307.65
1.5
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2186
8987
2.84
307.65
3.0
2.7
umol/l
9.2
9.4
0.15
2008
7792
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6881
43120
2.97
307.65
14.5
5.9
umol/l
11.6
12.1
2.27
6720
40761
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6236
37127
2.85
307.65
5.6
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4856
25976
2.71
307.65
3.3
2.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
6248
37173
2.86
307.65
10.3
4.6
g/l
33.2
34.8
80.44
6020
34132
(3032080) INR in Blood by Coagulation assay
5673
36988
2.26
307.65
9.5
10.8
inr
1.2
1.3
10.98
1492
10045
(3037121) Protein [Mass/volume] in Urine
988
2852
3.74
290.73
6.2
2.6
g/l
0.2
0.3
12.57
756
1096
(3023368) Bacteria identified in Blood by Culture
4215
25405
2.15
284.11
5.1
4.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3626
20627
2.20
283.17
5.3
4.0
%
87.8
85.2
8.04
3587
20107
(40768804) Tissue Pathology biopsy report
4867
31145
2.11
278.54
2.8
2.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
6354
45090
2.15
274.52
16.6
8.6
e9/l
4.0
4.3
23.12
5779
38966
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1738
7320
2.67
266.02
2.5
2.4
u/l
34.3
55.1
1.08
1614
6188
(3014576) Chloride [Moles/volume] in Serum or Plasma
2261
11469
2.26
226.08
9.2
6.7
mmol/l
105.0
104.4
8.54
2224
11212
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7802
62283
2.21
217.87
15.9
7.5
u/l
92.1
80.3
35.72
7573
58239
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2291
12268
2.13
196.42
2.2
2.7
%
18.3
21.8
28.26
2013
10271
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2386
13042
2.09
193.35
2.2
2.6
g/l
2.4
2.3
26.62
2272
11942
(3022948) Iron [Moles/volume] in Serum or Plasma
2506
14054
2.05
188.78
2.3
2.6
umol/l
10.7
12.3
21.06
2371
12861
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1427
6442
2.42
183.59
1.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3509
22322
1.89
181.20
2.4
2.3
mg/l
3.9
3.0
41.70
3036
18810
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3686
24032
1.85
174.48
4.7
3.2
u/l
36.7
35.9
0.11
3545
22591
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2760
16461
1.94
171.68
9.2
2.9
mmol/l
2.5
2.5
10.43
2587
14229
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
429
986
4.50
170.70
2.0
2.4
u/ml
224.4
660.6
0.70
422
968
(3013826) Glucose [Moles/volume] in Serum or Plasma
6353
49422
1.80
160.72
6.0
4.9
mmol/l
6.9
6.9
1.91
6120
46457
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2402
14119
1.93
153.30
5.2
3.0
mmol/l
0.8
0.8
16.36
2295
13036
(3015377) Calcium [Moles/volume] in Serum or Plasma
4088
28749
1.72
140.86
7.9
3.2
mmol/l
2.3
2.4
2.09
3731
24434
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
853
3418
2.64
139.49
2.6
2.8
u/ml
0.3
0.3
3.62
495
1956
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1085
4961
2.33
133.13
8.8
9.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5621
43555
1.67
130.61
8.3
6.8
mmol/l
1.2
1.2
30.79
4754
36380
(3003694) ABO and Rh group [Type] in Blood
2917
19084
1.75
127.24
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5171
39562
1.64
123.16
7.3
6.1
mmol/l
1.2
1.2
21.84
4795
35397
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1604
8811
1.98
121.79
8.2
7.7
g/l
115.7
120.6
21.14
1556
8481
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4245
31204
1.63
116.35
2.9
2.9
ug/l
135.4
159.8
3.65
3902
28187
(3016502) Oxygen saturation in Arterial blood
1709
9738
1.91
115.89
7.9
7.2
%
96.6
95.3
16.00
1654
9335
(40758558) Short blood count panel - Blood
2944
19855
1.69
112.06
12.8
6.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1817
10820
1.83
106.32
7.6
6.9
mmol/l
0.8
1.1
2.25
1480
8376
(3027801) Oxygen [Partial pressure] in Arterial blood
1812
10853
1.82
103.76
7.7
6.9
kpa
13.9
11.9
41.94
1741
10274
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1812
10860
1.82
103.52
7.7
6.9
kpa
5.1
5.1
2.86
1745
10301
(3002256) Pathology report gross observation
1776
10601
1.82
102.75
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1955
12060
1.77
101.07
2.2
2.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1425
7995
1.91
100.00
6.1
6.6
mmol/l
1.3
1.4
1.10
1367
7679
(3002582) Erythrocytes [#/volume] in Urine
3592
26502
1.56
89.82
3.6
3.5
e6/l
72.4
108.5
1.17
2945
20604
(3020779) Urea [Moles/volume] in Serum or Plasma
1442
8405
1.84
88.97
5.4
6.9
mmol/l
9.6
11.1
11.55
1376
7930
(3031040) Bacteria [#/volume] in Urine by Automated count
6419
53962
1.54
86.03
5.0
5.0
e6/l
2290.7
1669.9
0.26
96
865
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
315
970
3.32
82.24
4.2
3.3
nmol/l
7.2
12.3
0.39
308
945
(3026782) Osmolality of Urine
2528
17534
1.59
80.91
3.1
2.9
mosm/kgh2o
542.9
552.1
1.35
2238
14868
(3000991) Gas panel - Venous blood
1289
7548
1.81
77.54
7.2
8.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3269
24315
1.51
75.27
3.6
3.3
e6/l
0.5
0.5
0.14
2636
18553
(36304419) Bacteria [Presence] in Urine
3136
23260
1.51
72.55
3.5
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
602
2756
2.26
72.20
1.3
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4558
36591
1.46
69.90
5.0
5.9
%
2.7
2.9
5.77
4238
33714
(3019069) Monocytes/100 leukocytes in Blood
4578
36792
1.46
69.75
5.2
6.3
%
9.0
8.9
2.27
4257
34027
(3002030) Lymphocytes/100 leukocytes in Blood
4642
37476
1.45
68.62
5.2
6.1
%
23.4
26.3
50.43
4285
34439
(3022096) Basophils/100 leukocytes in Blood
4443
35605
1.45
68.14
5.0
6.0
%
0.6
0.7
19.70
4125
32836
(3039000) Anion gap in Blood
480
2064
2.39
66.50
8.3
6.8
mmol/l
11.1
11.3
0.79
438
1838
(3018572) Chloride [Moles/volume] in Blood
480
2064
2.39
66.50
8.3
6.8
mmol/l
106.3
104.9
8.41
438
1838
(3018095) Leukocytes [#/volume] in Urine
3839
30062
1.45
65.82
4.2
3.9
e6/l
130.5
112.0
0.65
3049
21965
(42870588) Differential panel, method unspecified - Blood
3567
27572
1.46
65.35
4.6
5.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
2569
18711
1.50
63.03
2.8
2.7
e6/l
5.4
4.6
1.85
2286
16343
(3018010) Neutrophils/100 leukocytes in Blood
4539
36893
1.43
62.41
4.9
5.9
%
60.6
58.4
23.25
4224
34061
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1005
5826
1.81
61.68
8.7
8.6
%
0.7
0.7
0.61
999
5784
(3025941) Bacteria identified in Stool by Culture
741
3920
1.96
60.41
1.3
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
56
41
13.73
60.40
1.0
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
747
3985
1.95
59.39
1.9
1.9
ug/l
1.9
2.3
0.53
670
3461
(3047181) Lactate [Moles/volume] in Blood
583
2846
2.11
59.32
7.6
6.0
mmol/l
1.4
1.3
1.21
523
2505
(3006315) Basophils [#/volume] in Blood
4746
39149
1.41
58.57
4.7
5.6
e9/l
0.0
0.0
12.07
4052
33320
(3001604) Monocytes [#/volume] in Blood
4709
38903
1.40
56.98
4.7
5.6
e9/l
0.6
0.6
0.56
4014
33064
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
989
5855
1.77
56.27
8.7
8.5
%
1.3
1.4
2.04
983
5815
(3026008) Bacteria identified in Urine by Culture
3420
26781
1.42
56.03
3.4
3.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4795
39861
1.39
55.25
4.9
5.7
e9/l
1.7
1.9
2.67
4169
34491
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
730
3972
1.90
54.57
6.5
5.0
%
1.6
1.6
0.29
684
3717
(3007930) Methemoglobin/Hemoglobin.total in Blood
722
3921
1.91
54.28
6.7
5.1
%
0.9
0.9
2.46
675
3670
(3013115) Eosinophils [#/volume] in Blood
4839
40365
1.39
54.20
4.9
5.8
e9/l
0.2
0.2
7.37
4203
34809
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
460
2134
2.21
53.20
2.0
2.4
g/l
3.7
3.6
0.25
450
2026
(3008152) Bicarbonate [Moles/volume] in Arterial blood
992
6034
1.72
51.03
8.7
6.9
mmol/l
24.4
24.6
0.48
939
5610
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8286
76330
1.53
50.76
28.6
16.8
mg/l
36.9
26.4
114.31
7681
62159
(3037467) Urinalysis macro (dipstick) panel - Urine
6304
55246
1.39
50.67
5.6
4.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1687
11709
1.53
50.41
4.7
5.6
mmol/l
1.0
1.0
1.57
1572
10760
(40768441) Liver Pathology biopsy report
177
518
3.46
50.13
1.1
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1609
11111
1.54
49.09
2.0
2.4
%
1.8
1.8
0.29
1422
9689
(3019060) Gas panel - Arterial blood
1039
6474
1.68
48.74
6.4
4.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
836
4923
1.76
48.14
8.6
8.7
mmol/l
24.0
24.3
3.12
807
4534
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
873
5246
1.73
46.76
6.8
6.9
mmol/l
24.6
24.8
0.72
867
5193
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1931
14012
1.47
45.96
3.4
3.1
e6/l
2.7
2.1
1.80
1164
7839
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5372
46303
1.35
45.28
3.7
3.1
u/l
70.2
54.5
13.51
5033
42042
(3018418) pH of Serum or Plasma
3234
25902
1.37
43.38
4.9
4.1
ph
7.4
7.4
1.57
696
4887
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
565
3063
1.90
42.50
2.7
4.0
u/ml
55.0
77.3
1.55
550
2937
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
398
1915
2.12
41.92
2.0
2.4
%
215.4
204.3
1.60
383
1808
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
417
2101
2.03
38.81
2.0
2.1
%
83.4
88.8
4.56
407
1972
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
785
4857
1.67
37.44
2.6
2.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1858
13935
1.41
35.82
2.0
2.0
s
30.1
30.1
0.05
1814
13499
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1994
15192
1.39
34.95
1.8
1.9
—
—
—
0
0
(3012544) pH of Venous blood
1279
9010
1.48
34.40
3.3
3.8
ph
7.4
7.4
—
6
47
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1241
8710
1.49
33.97
3.3
3.8
kpa
5.7
5.8
7.04
1201
8449
(3002032) Base excess in Venous blood by calculation
1233
8673
1.48
33.34
3.3
3.8
mmol/l
1.8
1.9
0.12
956
7051
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
357
1812
2.01
32.55
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1283
9208
1.45
31.13
4.8
3.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1942
15085
1.36
29.50
3.2
2.9
e6/l
1.2
1.3
0.40
1162
8838
(3023520) Reticulocytes [#/volume] in Blood
1178
8425
1.45
28.98
2.1
2.5
e9/l
69.2
68.4
0.29
914
6451
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
255
1193
2.17
28.91
5.8
6.4
mg/l
11.9
12.1
0.21
226
1076
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
236
1077
2.22
28.47
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
230
1051
2.22
27.67
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
228
1047
2.21
27.10
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
230
1062
2.19
26.97
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
227
1048
2.19
26.64
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
227
1051
2.19
26.45
1.4
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
207
931
2.25
25.90
1.1
1.1
g/l
1.6
1.5
1.41
195
832
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
438
2562
1.74
25.58
1.8
1.7
—
—
—
0
0
(3036489) Thrombin time
453
2707
1.71
24.49
1.9
1.9
s
21.2
21.9
1.82
428
2401
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1425
10847
1.37
24.13
3.1
4.1
u/l
249.9
248.5
0.10
1358
10166
(3019550) Sodium [Moles/volume] in Serum or Plasma
8439
80247
1.36
23.97
34.1
19.9
mmol/l
139.2
139.6
34.81
8302
78124
(3023103) Potassium [Moles/volume] in Serum or Plasma
8448
80397
1.35
23.44
34.1
20.1
mmol/l
4.0
4.0
24.55
8301
78153
(3019225) pH of Specimen
1214
9066
1.39
23.07
4.6
4.5
—
—
—
0
0
(3013512) EKG study
3054
25926
1.26
22.80
4.4
4.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
369
2144
1.75
22.08
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
366
2126
1.75
21.93
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3892
34079
1.23
21.64
15.4
10.2
e9/l
0.0
0.0
1.04
3182
27781
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
784
5476
1.47
21.56
1.5
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
368
2153
1.74
21.50
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
8194
77861
1.31
21.25
28.9
16.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1036
7664
1.39
20.72
1.7
2.1
ug/g
260.4
154.3
8.41
811
5928
(3051651) Icteric interference index of Serum or Plasma
128
515
2.50
20.67
5.8
3.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
633
4270
1.52
20.65
3.0
4.1
mmol/l
23.9
24.1
0.95
579
3807
(4281824)
169
778
2.19
20.08
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1275
9807
1.34
19.89
1.8
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7586
71554
1.26
19.77
29.1
15.9
ml/min/173m2
76.5
74.0
22.72
6838
59413
(40768797) Stomach Pathology biopsy report
1417
11110
1.32
19.34
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6932
73504
0.81
19.29
4.3
4.7
mmol/l
1.4
1.4
0.88
6175
66182
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7004
74183
0.81
19.26
4.3
4.8
mmol/l
4.5
4.5
0.37
6291
67288
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
885
11840
0.72
18.28
1.2
1.3
iu/ml
49.3
38.2
1.08
290
3613
(3024354) Oxygen [Partial pressure] in Venous blood
963
7183
1.38
18.23
3.0
3.2
kpa
4.5
4.5
0.41
924
6934
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1690
20561
0.79
17.45
1.7
1.6
mmol/l
1.4
1.3
3.43
1396
16922
(3023183) Ammonium ion [Moles/volume] in Plasma
303
1784
1.72
17.36
2.2
2.5
umol/l
32.3
33.9
0.59
255
1468
(3018405) Lactate [Moles/volume] in Arterial blood
506
3394
1.52
16.96
4.9
4.0
mmol/l
1.3
1.4
1.09
495
3334
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
568
3907
1.48
16.84
1.9
2.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2230
18786
1.24
16.80
1.8
1.8
nmol/l
1180.6
1156.4
0.51
1697
13909
(3052851) Hemolysis interference index of Serum or Plasma
416
2682
1.58
16.67
4.9
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
652
4619
1.44
16.58
1.5
1.6
g/l
1.8
1.6
5.62
561
3915
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
61
189
3.24
16.05
2.0
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
842
11121
0.73
15.85
1.2
1.2
u/ml
18.5
14.5
0.57
312
3964
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
972
7422
1.34
15.75
4.6
3.9
mmol/l
1.2
1.2
1.93
880
6409
(3020564) Creatinine [Moles/volume] in Serum or Plasma
8381
80501
1.27
15.69
36.3
19.8
umol/l
82.1
83.5
2.63
8376
80473
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6824
72023
0.83
15.40
6.4
6.5
mmol/mol
41.3
40.8
2.88
6123
65466
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7262
76163
0.82
15.11
4.8
5.4
mmol/l
2.6
2.6
1.30
6469
68778
(3033799) Differential panel - Peritoneal fluid
75
273
2.76
14.92
1.6
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
334
2109
1.60
14.66
4.4
4.3
mmol/l
2.7
2.6
0.14
241
1437
(3013290) Carbon dioxide [Partial pressure] in Blood
334
2111
1.60
14.60
4.4
4.3
kpa
5.0
5.0
0.01
328
2058
(3044889) 12 lead EKG panel
6023
56144
1.19
14.59
4.5
4.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
516
3592
1.46
14.41
1.9
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
178
947
1.90
14.35
5.1
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8355
80387
1.26
14.33
19.0
11.1
u/l
24.8
25.6
3.14
8163
76882
(3027315) Oxygen [Partial pressure] in Blood
334
2124
1.59
14.24
4.4
4.3
kpa
9.0
8.4
4.12
328
2070
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1304
10518
1.28
14.04
1.7
1.8
—
—
—
0
0
(3020891) Body temperature
536
3780
1.44
13.98
5.6
4.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
419
2830
1.50
13.62
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6965
65908
1.19
13.62
30.8
18.2
%
37.0
38.9
35.01
4399
41759
(3010421) pH of Blood
370
2435
1.54
13.59
4.2
4.2
ph
7.4
7.4
0.06
328
2059
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3808
34285
1.18
13.59
3.9
4.1
ng/l
40.1
82.6
2.12
3060
26113
(40761536) Microorganisms panel - Urine sediment
869
6707
1.32
13.02
4.5
4.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6437
60653
1.18
12.62
37.6
20.3
%
14.7
13.9
201.64
6355
59198
(3021162) Amylase [Enzymatic activity/volume] in Specimen
48
150
3.21
12.54
2.4
2.8
u/l
724.2
1990.1
0.82
42
140
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6776
71159
0.85
12.37
3.9
4.2
mmol/l
1.3
1.3
3.79
5990
63449
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
753
5735
1.34
12.36
1.8
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
631
4682
1.37
12.27
3.6
3.5
mmol/l
24.6
25.2
3.05
610
4549
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1282
10502
1.25
12.01
1.8
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
852
6651
1.31
11.75
4.1
2.7
ml/min/173m2
63.0
60.9
0.91
378
2757
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2044
17606
1.20
11.74
3.7
4.1
ng/l
483.5
498.1
0.03
1716
14964
(3022217) INR in Platelet poor plasma by Coagulation assay
1597
13432
1.23
11.70
24.4
29.7
inr
1.4
1.5
2.09
258
1779
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
126
647
1.96
11.39
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
96
450
2.14
11.11
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
96
450
2.14
11.11
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
314
2088
1.52
11.06
3.7
3.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
123
633
1.95
11.06
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
287
1877
1.54
10.92
1.2
1.2
titre
59.4
174.1
2.33
17
156
(3004119) Hemoglobin [Mass/volume] in Venous blood
739
5718
1.32
10.86
3.1
3.4
g/l
121.7
127.7
9.98
720
5577
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1656
14107
1.21
10.58
1.2
1.2
u/ml
1.9
1.9
0.01
415
3518
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5347
56838
0.87
10.18
3.5
3.9
pmol/l
15.0
15.0
0.24
4693
50620
(3043410) Blood group antigens tested for on Red Blood Cells
59
234
2.53
10.05
2.4
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1824
15811
1.19
9.54
4.1
4.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
70
309
2.27
9.45
1.4
2.2
e6/l
8754.4
5194.9
0.17
52
216
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
142
808
1.77
9.39
1.2
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
206
1305
1.59
9.08
1.9
1.8
ug/l
18.1
24.1
2.41
198
1270
(3024731) MCV [Entitic volume]
8514
82793
1.21
9.07
44.1
24.5
fl
91.2
91.7
17.02
8408
81243
(3007461) Platelets [#/volume] in Blood
8512
82773
1.21
9.07
44.3
24.6
e9/l
250.7
241.1
27.61
8357
80233
(3026361) Erythrocytes [#/volume] in Blood
8514
82798
1.21
9.04
44.2
24.6
e12/l
4.3
4.4
155.64
8338
79933
(3000963) Hemoglobin [Mass/volume] in Blood
8515
82810
1.21
9.03
44.5
24.7
g/l
126.7
133.8
302.05
8408
81273
(3035941) MCH [Entitic mass]
8513
82790
1.21
9.02
44.0
24.4
pg
30.1
30.5
62.58
8405
81237
(3037522) Nuclear Ab [Titer] in Serum
747
9320
0.79
8.99
1.3
1.3
titre
530.0
506.0
0.12
156
1983
(3034770) Mitochondria Ab [Titer] in Serum
277
1881
1.49
8.90
1.2
1.2
titre
401.7
899.2
—
6
61
(3010813) Leukocytes [#/volume] in Blood
8513
82815
1.20
8.85
44.3
24.6
e9/l
6.9
6.9
0.38
8347
79951
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3978
36742
1.14
8.73
2.1
2.1
pmol/l
88.0
93.6
11.52
2312
19180
(3043409) Potassium [Moles/volume] in Arterial blood
398
2900
1.39
8.73
5.5
4.3
mmol/l
3.8
3.9
6.28
372
2720
(3017181) Myelocytes/100 leukocytes in Blood
867
7046
1.25
8.64
3.3
4.0
%
1.0
1.0
0.29
340
2131
(3030981) Hyaline casts [#/volume] in Urine by Automated count
629
4920
1.30
8.56
3.2
2.9
e6/l
0.4
0.3
0.98
621
4827
(3021440) Promyelocytes/100 leukocytes in Blood
825
6687
1.25
8.41
3.2
4.0
%
0.2
0.1
0.31
315
1974
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
178
1112
1.61
8.35
2.1
3.7
u/ml
18.4
40.2
5.12
172
1075
(40767503) Oxygen content in Capillary blood by calculation
289
2006
1.45
8.34
2.6
2.6
%
15.3
15.9
1.36
139
1057
(3004809) Band form neutrophils/100 leukocytes in Blood
233
1550
1.52
8.30
2.6
3.6
%
2.4
1.5
2.10
182
1182
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
61
273
2.24
8.04
1.4
2.0
e6/l
17633.1
18088.5
0.01
43
153
(3041096) Erythrocytes [Presence] in Urine by Automated
2233
19920
1.16
7.98
4.5
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
318
2271
1.41
7.88
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7222
74749
0.87
7.77
4.7
5.1
mmol/l
6.2
6.1
4.96
6424
66754
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
277
1936
1.44
7.73
1.2
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
225
1510
1.50
7.72
3.0
3.2
e9/l
4.3
4.4
0.31
225
1505
(3028626) Oxygen [Partial pressure] in Capillary blood
297
2108
1.42
7.63
3.6
2.9
kpa
8.0
7.8
0.62
280
1933
(3013707) Erythrocyte sedimentation rate by Westergren method
6101
58164
1.13
7.52
3.7
4.3
mm/h
17.6
14.0
39.04
5521
53143
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
553
4333
1.29
7.46
2.5
2.7
%
0.7
0.7
0.28
535
4150
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
559
4391
1.29
7.40
4.2
4.1
%
48.2
47.5
0.33
554
4336
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
563
4428
1.29
7.38
2.6
2.7
%
1.1
1.2
1.06
557
4401
(3021901) Oxygen saturation in Capillary blood
258
1797
1.45
7.36
2.9
2.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2453
27051
0.88
7.25
2.1
2.2
u/l
235.3
221.9
0.26
2311
25198
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1913
17005
1.15
7.08
1.7
1.7
mg/l
2.0
1.4
5.70
1563
13240
(3044007) Cell count panel - Peritoneal fluid
54
244
2.22
7.00
1.6
2.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
772
6364
1.23
6.77
3.0
3.8
%
0.8
0.7
0.52
228
1533
(3009261) Glucose [Presence] in Urine by Test strip
4180
39153
1.12
6.64
4.3
4.1
estimate
0.0
0.0
2.20
919
6935
(3021601) Nitrite [Presence] in Urine by Test strip
4129
38677
1.12
6.51
5.7
5.3
estimate
0.0
0.0
0.33
931
7140
(40761539) Cells [Type] in Urine sediment by Light microscopy
49
220
2.23
6.48
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1018
8668
1.19
6.40
2.9
3.0
ng/l
227.0
241.6
0.52
927
7934
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
315
4211
0.74
6.40
1.3
1.3
au/ml
60.9
57.2
0.10
18
175
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
813
6778
1.22
6.39
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
283
2064
1.38
6.28
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
283
2064
1.38
6.28
1.2
1.3
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
23
71
3.24
6.26
2.2
2.2
%
62.0
66.7
0.26
17
46
(3020393) Adenovirus Ag [Presence] in Stool
23
71
3.24
6.26
1.1
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
763
6339
1.22
6.22
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2026
22423
0.88
6.15
2.7
2.9
umol/l
4072.2
5810.7
1.20
1745
18982
(3000570) Elastase.pancreatic [Mass/mass] in Stool
330
2476
1.34
6.13
1.4
1.4
ug/g
245.8
263.4
0.87
211
1506
(3026692) Albumin [Mass/volume] in Peritoneal fluid
49
228
2.15
5.97
1.1
1.6
g/l
14.6
13.6
0.40
41
177
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
89
510
1.75
5.91
2.3
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
60
303
1.99
5.90
2.3
3.9
%
55.8
54.3
0.22
60
290
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
360
4662
0.76
5.86
2.4
2.4
au/ml
40.0
25.0
0.57
15
159
(1761482) Bacteria [#/volume] in Urine by Culture
345
2626
1.33
5.83
5.0
4.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
687
5693
1.22
5.75
3.7
3.6
mmol/l
1.9
1.8
0.12
492
4219
(3025159) Blasts/100 leukocytes in Blood
745
6224
1.21
5.75
3.3
4.0
%
0.3
0.4
0.18
250
1665
(3035350) Ketones [Presence] in Urine by Test strip
4107
38647
1.11
5.68
4.2
4.0
estimate
0.0
0.0
0.50
915
7075
(4010399)
477
5930
0.79
5.59
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
176
2522
0.69
5.51
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
79
448
1.77
5.47
1.4
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
79
448
1.77
5.47
1.4
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
79
448
1.77
5.47
1.4
1.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
82
471
1.75
5.44
1.8
1.9
u/field
2.5
1.8
0.44
63
317
(1002224) Polysomnography panel
147
2167
0.67
5.37
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2036
22356
0.89
5.33
3.0
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
599
7226
0.82
5.31
1.5
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
704
5898
1.21
5.30
3.7
3.7
ph
7.4
7.4
0.08
94
740
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
712
5979
1.21
5.23
3.7
3.7
kpa
5.1
5.2
2.53
663
5479
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
121
777
1.56
5.23
1.7
2.2
u/field
2.8
1.7
1.06
51
280
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
78
448
1.75
5.19
1.4
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1413
12551
1.15
5.19
1.4
1.5
g/l
2.7
2.6
0.03
791
7208
(3029937) Albumin [Presence] in Urine by Test strip
2332
21384
1.12
5.13
4.4
4.5
estimate
0.0
0.0
0.47
835
6761
(3021960) Folate [Moles/volume] in Serum or Plasma
2353
21593
1.12
5.10
1.6
1.6
nmol/l
20.3
20.1
0.25
2023
18261
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
27
639
0.42
5.10
1.0
1.0
ng/l
38.1
43.9
0.43
18
414
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
27
636
0.42
5.05
1.0
1.0
ng/l
672.2
706.0
0.21
18
411
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
27
635
0.42
5.03
1.0
1.0
ng/l
258.2
327.2
1.83
18
420
(3015171) Extractable nuclear Ab [Units/volume] in Serum
189
2615
0.72
4.87
1.1
1.2
u/ml
3.6
0.9
0.67
17
255
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3105
28978
1.10
4.85
2.8
3.2
ng/l
1642.6
1771.6
0.75
2687
25141
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
64
355
1.81
4.82
1.5
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
280
2134
1.32
4.76
1.3
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
90
554
1.63
4.68
2.7
2.5
ph
7.4
7.4
1.08
33
204
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
412
3308
1.26
4.68
2.0
2.2
ug/l
381.1
652.3
2.06
401
3130
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
139
944
1.48
4.68
2.7
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1045
9152
1.16
4.67
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6738
69403
0.91
4.65
4.3
4.8
mu/l
2.5
2.1
0.56
5924
62122
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
63
352
1.79
4.65
1.5
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
63
352
1.79
4.65
1.5
2.1
—
—
—
0
0
(4094501)
153
2164
0.70
4.52
1.1
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
290
2241
1.30
4.49
3.7
3.4
mmol/l
1.7
1.7
0.00
284
2189
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
18
61
2.95
4.27
2.3
2.1
%
17.0
13.0
—
10
37
(3033705) Calcium.ionized [Moles/volume] in Venous blood
181
1315
1.38
4.25
2.9
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
267
2061
1.30
4.19
1.3
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
490
5882
0.82
4.18
2.0
2.1
nmol/l
10.2
12.1
5.23
419
5069
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
366
2941
1.25
4.17
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
130
1860
0.69
4.14
1.4
1.7
mg/l
3.3
3.6
0.17
103
1354
(3045683) HLA typing for celiac disease panel - Blood or Tissue
52
285
1.83
4.12
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
103
1537
0.67
4.10
1.3
1.4
e6/l
228.8
1191.6
3.60
84
1253
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
103
1534
0.67
4.06
1.2
1.3
e6/l
18.5
24.6
0.21
83
1182
(4034850)
195
2599
0.75
4.02
14.2
11.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
209
1570
1.34
4.00
1.3
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
175
2364
0.74
3.95
1.4
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
82
1272
0.64
3.95
1.1
1.2
u/ml
60.6
44.8
—
5
138
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
104
1536
0.67
3.95
1.2
1.2
mmol/l
3.9
3.9
0.07
99
1436
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
72
440
1.64
3.92
3.1
3.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
110
1600
0.68
3.86
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
32
152
2.11
3.82
2.9
4.4
u/l
64.1
40.8
—
8
52
(3006184) Hemoglobin [Mass/volume] in Capillary blood
271
2126
1.28
3.80
2.3
2.3
g/l
121.3
127.3
3.46
205
1529
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
57
330
1.73
3.80
2.4
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
257
2005
1.29
3.77
1.7
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
308
2459
1.26
3.75
3.0
3.1
mmol/l
24.1
24.9
2.34
272
2135
(3001893) Eosinophils/100 leukocytes in Pleural fluid
58
341
1.70
3.67
1.4
1.5
%
3.0
2.6
0.11
44
286
(3024891) Influenza virus A+B Ag [Presence] in Specimen
236
1832
1.30
3.61
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
212
1626
1.31
3.55
1.1
1.1
u/ml
5.3
11.3
0.94
18
128
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1843
19937
0.91
3.50
3.1
3.2
ug/l
0.8
0.8
0.18
1293
14205
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
323
3957
0.81
3.43
1.8
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2065
19176
1.10
3.41
1.7
1.7
pmol/l
8673005.1
28839989.2
2.18
1695
15451
(21494755) Public health laboratory ask at order entry panel
268
3346
0.80
3.39
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
34
627
0.54
3.29
1.1
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
20
84
2.38
3.22
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
239
1890
1.27
3.21
1.8
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
200
2567
0.77
3.20
1.5
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
67
1032
0.65
3.20
3.6
4.3
umol/l
329.5
349.9
0.55
53
865
(3005322) IgE [Units/volume] in Serum or Plasma
318
3864
0.82
3.15
1.2
1.3
u/ml
215.5
244.5
0.30
288
3526
(3045424) Erythrocytes [Presence] in Urine
175
1337
1.31
3.07
1.8
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
108
765
1.42
3.05
1.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
108
765
1.42
3.05
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
108
765
1.42
3.05
1.4
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
84
567
1.49
3.05
1.6
1.9
u/l
268.3
1446.8
1.57
24
213
(3014271) Vancomycin [Susceptibility]
88
605
1.46
2.93
2.9
3.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
36
198
1.82
2.92
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
134
1789
0.75
2.90
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
265
3242
0.81
2.84
1.2
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
63
407
1.55
2.83
1.4
1.5
%
55.1
67.2
1.62
46
334
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
728
8188
0.88
2.80
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
181
2306
0.78
2.78
1.4
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
150
1140
1.32
2.77
1.4
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
284
0.39
2.72
1.1
1.8
ug/l
23.9
144.3
0.64
11
259
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2661
28054
0.93
2.67
4.3
4.7
%
21.6
22.2
1.16
1372
14841
(3022493) Free Hemoglobin [Mass/volume] in Plasma
56
360
1.56
2.60
1.5
4.4
mg/l
60.2
69.3
0.49
38
254
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3103
29582
1.07
2.59
4.7
4.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
31
543
0.57
2.58
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
493
4281
1.16
2.58
3.9
3.8
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
50
314
1.60
2.56
1.2
1.3
ug/l
1024.9
313.5
0.71
31
168
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
8
20
4.00
2.56
1.9
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
112
828
1.36
2.52
1.5
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
75
517
1.45
2.52
1.4
1.7
umol/l
81.8
69.9
—
6
32
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
39
2.82
2.47
1.1
1.2
u/field
1.0
1.2
—
6
24
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
66
449
1.47
2.39
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
66
449
1.47
2.39
1.3
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
187
1496
1.25
2.38
1.4
1.5
g/l
30.6
31.6
0.49
167
1321
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
169
2115
0.80
2.30
1.5
1.6
iu/ml
3.3
6.8
0.39
42
519
(3028707) Methadone [Presence] in Urine by Screen method
20
383
0.52
2.29
1.4
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
186
0.38
2.26
2.4
4.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
116
880
1.32
2.24
1.5
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
34
201
1.69
2.23
1.2
1.4
g/l
26.8
27.1
0.04
27
157
(3000475) Leukocytes [#/volume] in Synovial fluid
173
2151
0.80
2.23
1.6
1.6
e6/l
14661.2
15238.0
0.07
130
1524
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
618
0.63
2.23
1.3
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
571
5069
1.13
2.22
1.1
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
5
9
5.56
2.21
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
217
2627
0.82
2.18
2.6
2.2
g/l
0.0
0.0
0.00
199
2386
(3011288) Drugs identified in Urine by Screen method
31
514
0.60
2.15
1.1
2.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
130
1009
1.29
2.14
1.3
1.3
u/l
805.5
407.6
0.37
122
954
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
411
0.56
2.12
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
104
1366
0.76
2.11
1.7
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
44
284
1.55
2.07
3.2
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
44
284
1.55
2.07
3.2
2.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
102
770
1.33
2.07
1.3
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
75
540
1.39
2.05
1.5
1.6
u/l
6.9
6.1
0.12
37
245
(3035880) pH of Pleural fluid
82
600
1.37
2.04
1.2
1.3
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
22
118
1.87
2.01
1.0
1.2
ng/l
103.9
799.0
—
9
85
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
139
1746
0.79
2.00
1.6
1.7
nmol/l
39.8
44.4
1.99
131
1661
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
140
1.79
2.00
1.0
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
9
32
2.81
2.00
1.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
123
962
1.28
1.95
2.6
3.5
%
59.5
58.3
0.19
70
610
(3000919) Neutrophils/100 leukocytes in Pleural fluid
46
305
1.51
1.94
1.4
1.4
%
25.2
17.9
1.01
39
276
(44816559) Phosphatidylethanol [Mass/volume] in Blood
81
1087
0.74
1.94
1.2
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
68
487
1.40
1.93
2.1
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
124
973
1.28
1.92
1.3
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
67
480
1.40
1.91
2.1
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1640
17395
0.93
1.91
4.4
4.6
kg/l
1.0
1.0
0.08
290
2704
(3000492) Spirometry study
586
6507
0.89
1.90
1.4
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
94
712
1.32
1.89
1.0
1.1
u/ml
5.6
3.5
0.30
34
236
(3023199) Leukocytes [#/volume] in Pleural fluid
163
1324
1.23
1.88
1.4
1.5
e6/l
1015.0
2356.9
4.81
127
958
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
129
1020
1.27
1.88
1.3
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
319
0.53
1.88
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
125
1574
0.79
1.86
1.2
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
32
197
1.63
1.85
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
521
4661
1.12
1.84
5.5
3.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
149
1202
1.24
1.84
1.4
1.5
e6/l
122615.5
56991.6
0.67
101
712
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
122
1538
0.79
1.84
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
58
809
0.72
1.80
1.2
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
468
4168
1.13
1.79
2.8
2.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
324
3718
0.87
1.78
1.1
1.2
iu/ml
144.7
129.7
0.26
106
1305
(3020876) Protein [Mass/time] in 24 hour Urine
106
825
1.29
1.77
1.9
1.9
—
0.9
—
0
34
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
47
2.34
1.77
1.2
1.2
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
19
102
1.86
1.75
1.3
1.2
ug/l
44.4
116.6
4.65
11
64
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
29
461
0.63
1.75
1.2
1.4
pmol/l
123.7
125.7
—
9
142
(3044290) Cell count panel - Cerebral spinal fluid
109
1382
0.79
1.74
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
335
3828
0.87
1.74
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
448
0.62
1.74
1.5
1.7
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
9
36
2.50
1.73
1.0
1.1
nmol/l
195.6
270.3
—
9
36
(3027008) Opiates [Presence] in Urine
58
803
0.72
1.73
1.2
1.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
28
170
1.65
1.73
1.0
1.3
umol/l
1.9
3.0
2.49
21
153
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
28
171
1.64
1.69
1.5
1.5
%
11.5
9.1
0.15
13
86
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
413
3666
1.13
1.68
4.2
4.0
mmol/l
24.7
24.8
0.34
371
3329
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
228
2673
0.85
1.68
2.6
2.2
g/l
0.0
0.0
0.63
201
2395
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
114
903
1.27
1.68
1.1
1.2
u/l
92.6
62.1
0.86
76
589
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
178
2132
0.83
1.67
1.5
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
179
1491
1.20
1.66
3.2
5.0
iu/ml
335.7
2210.9
0.96
19
226
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
21
119
1.77
1.65
1.5
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
175
2094
0.83
1.64
1.3
1.5
g/l
0.2
0.2
0.29
165
1973
(3003181) Sodium [Moles/volume] in Urine
201
1695
1.19
1.63
1.4
1.3
mmol/l
58.0
62.3
0.76
141
1356
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
286
3286
0.87
1.63
2.5
2.3
g/l
0.9
1.0
0.19
238
2749
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
98
1.84
1.61
1.1
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
32
2.50
1.59
3.5
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
32
2.50
1.59
7.0
6.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
47
328
1.43
1.59
1.5
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
17
300
0.57
1.57
1.2
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
173
0.46
1.57
1.5
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
126
1019
1.24
1.57
2.9
4.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
60
439
1.37
1.56
1.1
1.1
u/l
87.7
95.5
0.33
53
331
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
183
2170
0.84
1.56
1.3
1.5
g/l
1.1
1.2
0.47
172
2046
(3047189) Immunofixation for 24 hour Urine
32
483
0.66
1.56
1.6
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
261
2261
1.16
1.54
3.1
3.1
nmol/l
0.8
0.8
0.20
203
1736
(3000764) Benzodiazepines [Presence] in Urine
59
797
0.74
1.54
1.2
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
154
1852
0.83
1.54
1.1
1.2
u/ml
43.0
41.2
—
6
95
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
79
1022
0.77
1.52
1.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
55
748
0.73
1.51
1.2
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
24
146
1.65
1.50
1.8
1.8
ug/l
2.7
5.8
0.59
15
93
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
175
1471
1.19
1.50
2.9
3.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
64
477
1.34
1.50
2.4
2.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
184
0.49
1.49
1.2
1.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
45
0.00
1.49
0.0
11.5
—
203.5
—
0
37
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
248
2857
0.86
1.49
2.6
2.2
g/l
0.1
0.0
0.29
221
2571
(3006576) Bicarbonate [Moles/volume] in Blood
47
333
1.41
1.49
5.3
6.6
mmol/l
25.0
24.8
0.09
40
296
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
380
0.63
1.47
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
145
1744
0.83
1.47
1.1
1.2
u/ml
2.7
7.3
3.43
27
281
(3000012) Reticulocyte production index
73
557
1.31
1.46
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
81
1038
0.78
1.46
1.1
1.2
miu/ml
149.6
205.6
0.74
26
367
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
104
1292
0.80
1.45
1.7
1.8
pmol/l
193.9
196.7
0.09
99
1192
(4027681)
18
304
0.59
1.44
1.3
1.2
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
22
2.73
1.43
1.2
1.0
u/ml
0.1
0.0
—
6
13
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
59
438
1.35
1.43
1.1
1.1
u/l
35.1
31.9
0.14
49
319
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
303
0.59
1.42
1.1
1.1
u/l
2.6
1.1
—
10
150
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
59
785
0.75
1.42
1.1
1.2
mmol/l
7.6
7.9
0.29
48
550
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
155
0.45
1.41
1.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
144
1725
0.83
1.41
1.1
1.2
u/ml
8.3
6.5
0.16
16
184
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
82
640
1.28
1.40
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
103
827
1.25
1.40
3.3
3.0
mg/l
53.8
47.6
0.09
76
611
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
326
0.61
1.40
1.1
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
28
423
0.66
1.40
1.2
1.1
mg/l
43.2
44.0
0.04
23
359
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
22
350
0.63
1.39
1.2
1.1
ratio
1.1
1.1
—
6
111
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
89
1.80
1.36
1.9
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
32
467
0.68
1.35
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1047
11135
0.93
1.35
11.8
8.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
51
687
0.74
1.35
1.1
1.1
—
3.2
—
0
9
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
466
0.69
1.34
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
466
0.69
1.34
1.1
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
12
221
0.54
1.32
1.0
1.2
—
29.5
—
0
32
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
266
3014
0.88
1.30
2.4
2.1
g/l
37.1
37.2
0.10
212
2530
(3006270) Folate [Moles/volume] in Blood
101
818
1.24
1.29
1.3
1.2
nmol/l
317.0
333.7
0.33
75
630
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
232
0.56
1.29
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
60
784
0.76
1.29
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
355
0.65
1.29
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
462
0.69
1.29
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
32
462
0.69
1.29
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
461
0.69
1.28
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
192
0.52
1.27
1.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
119
984
1.21
1.26
1.3
1.4
mmol/l
6.6
6.4
0.27
111
898
(40768795) Lymph node Pathology biopsy report
100
815
1.23
1.23
1.2
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
41
296
1.39
1.21
2.3
2.7
—
31.7
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
113
1361
0.83
1.21
1.3
1.4
—
—
—
0
0
(44813793)
27
397
0.68
1.21
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
71
557
1.28
1.21
2.4
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
397
3600
1.11
1.20
2.2
2.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
5
20
2.50
1.15
1.0
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
568
5251
1.09
1.15
4.0
3.1
e9/l
4.0
4.2
0.66
422
3771
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
214
2434
0.88
1.14
1.4
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
47
352
1.34
1.13
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
56
721
0.78
1.12
1.3
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
34
471
0.72
1.12
1.6
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
283
2532
1.12
1.11
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
147
1257
1.17
1.11
1.3
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
136
1595
0.85
1.10
1.5
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
129
1092
1.18
1.10
9.3
13.0
mmol/l
7.0
7.4
1.04
114
884
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
78
628
1.24
1.10
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
135
1148
1.18
1.09
1.4
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
256
0.62
1.08
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
18
112
1.61
1.08
2.6
2.6
u/field
0.8
0.4
0.88
18
112
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
43
570
0.75
1.07
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
121
1022
1.19
1.06
1.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
69
550
1.26
1.06
1.4
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
546
0.75
1.06
2.5
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
640
6856
0.93
1.06
2.3
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
63
498
1.27
1.04
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
3135
30528
1.04
1.04
3.9
3.8
ph
5.7
5.7
—
5
31
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
69
552
1.25
1.04
1.4
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
329
3622
0.91
1.03
2.3
2.2
g/l
10.2
10.3
0.07
268
2988
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
78
634
1.23
1.02
1.1
1.1
%
97.4
94.6
0.45
69
583
(4146454)
122
1037
1.18
1.01
2.8
2.7
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
48
1.88
1.00
2.0
2.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
15
238
0.63
1.00
1.4
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
31
426
0.73
0.99
2.6
2.6
%
33.9
35.6
—
7
157
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
65
807
0.80
0.99
1.6
1.7
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
11
61
1.80
0.98
1.3
1.3
ml/s/173m2
0.5
0.9
—
6
37
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
40
527
0.76
0.98
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
31
424
0.73
0.97
1.9
1.6
u/l
4.7
6.4
2.35
26
359
(3010144) Erythrocytes [#/volume] in Synovial fluid
71
871
0.81
0.97
1.5
1.3
e6/l
73673.1
171650.3
1.58
48
593
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
61
486
1.26
0.97
1.3
1.4
umol/l
15.2
14.1
0.36
56
459
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
37
275
1.35
0.96
1.3
1.4
%
24.1
22.9
0.09
28
228
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
198
1753
1.13
0.96
1.5
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
51
648
0.79
0.95
1.1
1.1
—
75.6
—
0
13
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
85
1.65
0.94
1.5
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
139
1601
0.87
0.93
1.6
1.7
iu/l
6.9
4.6
0.64
44
500
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
160
1400
1.15
0.93
1.3
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
78
642
1.22
0.93
1.4
2.1
%
11.0
10.8
0.20
78
642
(3036670) Protein [Mass/volume] in Synovial fluid
22
316
0.70
0.92
1.1
1.2
g/l
39.0
39.4
0.05
13
160
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
52
409
1.27
0.92
1.1
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
52
1.73
0.92
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
55
436
1.26
0.92
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
68
553
1.23
0.91
1.6
1.6
ml
1794.0
1883.0
0.23
23
147
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
296
3251
0.91
0.91
2.8
3.1
ratio
1.4
3.3
2.16
17
257
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
52
410
1.27
0.91
1.1
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
326
0.70
0.90
1.2
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
102
1.57
0.90
1.1
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
305
3342
0.91
0.90
2.8
3.1
mg/l
80.3
74.9
0.08
256
2705
(3028026) IgM [Mass/volume] in Serum or Plasma
411
4441
0.92
0.89
2.0
1.8
g/l
1.5
1.3
0.38
371
3971
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
58
718
0.81
0.88
1.9
1.7
mg/l
4.8
4.5
0.20
53
680
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
42
1.91
0.88
4.1
2.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
94
794
1.19
0.87
1.3
1.3
u/l
15.2
13.5
0.19
84
720
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
98
1151
0.85
0.87
1.4
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
70
847
0.83
0.86
1.1
1.1
au/ml
11.9
12.5
—
5
34
(3023410) Appearance of Cerebral spinal fluid
52
649
0.80
0.86
1.4
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
306
3342
0.91
0.85
2.8
3.1
mg/l
40.2
49.9
1.09
256
2704
(40761535) Cells panel - Urine sediment
714
7551
0.94
0.85
3.5
3.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
24
333
0.72
0.85
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
116
1341
0.86
0.84
1.4
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
527
5628
0.93
0.84
2.6
2.7
g/l
10.3
10.6
0.76
476
5131
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
17
251
0.68
0.84
1.1
1.1
%
87.1
94.2
0.44
12
187
(40768800) Prostate Pathology biopsy report
205
2283
0.90
0.84
1.2
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
33
435
0.76
0.84
1.2
1.1
nmol/l
3.0
10.6
1.00
11
93
(3051101) Glucose [Moles/volume] in Cord blood
12
191
0.63
0.84
4.3
6.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
153
1349
1.14
0.83
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
142
1246
1.14
0.82
1.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
89
1048
0.85
0.82
1.2
1.2
u/ml
284.8
291.3
0.07
58
645
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
1134
0.85
0.82
1.2
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
54
667
0.81
0.82
1.3
1.3
titre
116.0
287.8
—
5
60
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
115
0.52
0.82
1.2
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
70
840
0.83
0.80
1.5
1.5
%
30.5
28.4
0.19
45
527
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
357
3859
0.92
0.80
2.3
2.2
g/l
3.8
3.8
0.38
243
2707
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
133
1514
0.88
0.79
1.2
1.3
u/l
36.8
40.9
0.18
114
1298
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
358
3867
0.92
0.79
2.3
2.2
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.3
—
0
12
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
47
586
0.80
0.79
1.6
2.1
mmol/l
7.8
7.0
0.77
33
396
(3037756) Immunofixation for Serum or Plasma
197
2188
0.90
0.79
1.6
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
63
761
0.83
0.78
1.7
1.6
u/ml
34.3
25.3
0.72
12
162
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
96
0.52
0.78
1.2
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
34
440
0.77
0.77
1.7
2.2
e9/l
0.2
0.2
0.93
29
389
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
359
3872
0.92
0.77
2.3
2.2
g/l
7.6
7.4
0.91
259
2815
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
923
8817
1.05
0.77
2.2
2.4
ug/l
5.2
7.1
3.23
777
7534
(44786800) Granulocytes/100 leukocytes in Body fluid
20
140
1.43
0.76
1.3
1.3
%
28.4
23.7
0.21
14
104
(3008116) Ketones [Moles/volume] in Urine by Test strip
22
157
1.40
0.76
1.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
245
0.69
0.76
1.6
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
438
4092
1.07
0.76
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
23
166
1.39
0.75
1.4
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
24
2.08
0.74
2.8
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
166
1485
1.12
0.74
1.3
1.5
nmol/l
0.9
0.8
0.49
139
1222
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
71
597
1.19
0.73
1.3
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
5
25
2.00
0.72
1.2
1.1
%
1.5
1.3
—
5
25
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
709
6739
1.06
0.72
1.5
1.7
%
1.6
1.6
0.15
604
5672
(3009445) Proteinase 3 Ab [Units/volume] in Serum
344
3703
0.93
0.72
1.4
1.5
u/ml
24.8
19.3
—
6
92
(3021387) Prolactin [Units/volume] in Serum or Plasma
101
1161
0.87
0.72
1.8
1.7
mu/l
262.7
302.1
1.04
93
1071
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
12
76
1.58
0.71
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
59
489
1.21
0.71
2.2
2.1
ug/min
48.7
170.9
1.55
11
120
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
122
1074
1.14
0.71
1.3
1.3
nmol/l
0.6
2.7
0.83
114
1025
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
108
943
1.15
0.70
1.3
1.3
nmol/l
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
43
533
0.81
0.70
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
58
1.55
0.69
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
14
205
0.68
0.69
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
14
205
0.68
0.69
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
14
205
0.68
0.69
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
14
205
0.68
0.69
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
146
0.62
0.69
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
50
411
1.22
0.66
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
49
402
1.22
0.66
4.6
3.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
335
3593
0.93
0.65
2.4
2.3
g/l
3.2
3.1
0.56
250
2756
(40760888) Immunoglobulin light chains.free panel - Serum
231
2514
0.92
0.65
2.5
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
141
1263
1.12
0.64
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
28
360
0.78
0.64
1.1
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
21
281
0.75
0.63
1.3
1.2
g/l
—
0.3
—
0
23
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
49
405
1.21
0.62
1.3
1.2
—
—
—
0
0
(4211845)
53
442
1.20
0.62
4.4
3.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
279
0.75
0.61
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
29
226
1.28
0.61
5.2
8.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
92
1048
0.88
0.60
2.1
1.9
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
3.7
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
2.9
—
0
21
(3047007) Chlamydophila sp Ab [Presence] in Serum
68
791
0.86
0.60
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
173
1576
1.10
0.59
1.2
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
133
1195
1.11
0.59
1.9
2.2
mg/l
39.0
26.6
0.79
32
297
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
162
0.68
0.58
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3285
32296
1.03
0.58
2.2
2.2
nmol/l
76.2
79.1
6.76
2916
28194
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
41
336
1.22
0.58
1.9
2.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
20
265
0.75
0.58
1.7
1.8
mmol/l
-0.2
0.6
0.55
20
244
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
295
3159
0.93
0.58
1.7
1.8
u/l
38.5
38.5
0.01
261
2691
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
121
1083
1.12
0.58
1.3
1.3
nmol/l
0.2
0.3
—
6
83
(3045142) Bone marrow Pathology biopsy report
116
1036
1.12
0.57
1.2
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
12
173
0.69
0.57
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
193
1.30
0.57
1.1
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
105
933
1.13
0.57
1.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
68
586
1.16
0.56
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
111
990
1.12
0.56
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
385
4082
0.94
0.56
3.1
3.2
pmol/l
4.3
4.4
1.46
339
3551
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
19
141
1.35
0.56
1.2
1.2
u/l
34.4
284.4
0.57
13
97
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
87
0.57
0.56
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2776
28276
0.97
0.56
4.2
4.0
mg/mmol
10.6
9.6
0.47
1820
17818
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
172
0.70
0.56
1.3
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
38
462
0.82
0.56
1.7
2.2
e6/l
564.4
494.0
0.43
31
389
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
263
0.76
0.55
1.2
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
182
1983
0.92
0.55
1.7
1.9
mg/l
11.5
12.1
0.40
167
1817
(3029075) Extractable nuclear Ab panel - Serum
13
183
0.71
0.55
1.0
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
62
720
0.86
0.55
1.1
1.1
u/ml
0.9
1.8
1.18
21
280
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
228
0.75
0.54
1.0
1.1
miu/ml
1585.8
1633.9
0.05
17
228
(3029396) Erythrocyte agglutination [Presence] in Blood
6
38
1.58
0.54
1.7
2.0
—
—
—
0
0
(4015189)
22
284
0.77
0.54
1.9
2.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
45
376
1.20
0.54
1.2
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
159
0.69
0.54
2.5
3.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
99
1109
0.89
0.52
1.4
1.6
g/l
0.9
0.8
0.23
76
842
(3012516) Albumin [Mass/volume] in Urine
2625
26733
0.98
0.52
3.3
3.2
mg/l
300.1
391.5
0.62
1775
17007
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
812
0.87
0.52
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
28
223
1.26
0.52
1.9
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
43
511
0.84
0.51
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
42
500
0.84
0.51
1.9
2.3
e6/l
435.4
580.0
1.01
16
208
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
168
0.71
0.50
1.3
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
156
0.70
0.49
1.5
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2672
27184
0.98
0.49
3.3
3.2
mmol/l
7.5
7.3
0.94
2183
22310
(3036481) Cortisol [Moles/volume] in Serum or Plasma
701
6744
1.04
0.49
2.3
2.2
nmol/l
399.4
378.4
1.85
650
6122
(3022621) pH of Urine by Test strip
576
5518
1.05
0.49
3.2
3.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
84
1.43
0.49
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
116
1281
0.90
0.49
1.2
1.3
iu/l
38.3
33.8
0.63
93
1086
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
100
1112
0.90
0.48
1.7
1.5
%
63.3
61.4
0.17
63
702
(4268621)
68
596
1.14
0.48
2.3
2.3
—
—
—
0
0
(4133840)
22
172
1.28
0.48
1.2
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
28
344
0.81
0.47
1.1
1.3
mmol/l
6.1
6.2
0.17
28
322
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
592
0.86
0.47
1.0
1.1
u/ml
1.7
1.0
0.34
20
240
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
177
0.73
0.47
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
229
2140
1.07
0.46
1.4
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
22
173
1.27
0.46
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
210
0.76
0.46
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
99
892
1.11
0.45
1.2
1.2
u/ml
2.5
4.3
2.64
51
380
(3045716) Anion gap in Serum or Plasma
50
430
1.16
0.45
2.9
2.2
mmol/l
9.5
9.1
0.33
33
336
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
83
0.60
0.45
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
119
0.67
0.45
1.5
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
265
0.79
0.45
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
134
1461
0.92
0.45
1.1
1.2
u/ml
4.6
5.3
0.09
12
112
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
12
86
1.40
0.44
5.4
8.7
umol/l
0.3
0.3
0.08
12
79
(3032352) Blasts [#/volume] in Cerebral spinal fluid
10
69
1.45
0.44
1.5
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
275
1.20
0.43
2.0
1.9
—
—
—
0
0
(40758358) Immune stain study
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
182
1950
0.93
0.41
1.6
1.7
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
170.3
—
0
15
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
15
0.00
0.41
0.0
7.5
—
71.1
—
0
15
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
83
921
0.90
0.41
1.1
1.1
—
—
—
0
0
(4062490)
63
710
0.89
0.40
1.2
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
56
492
1.14
0.40
1.3
1.2
mmol/l
10.9
11.7
0.34
21
155
(3020630) Protein [Mass/volume] in Serum or Plasma
793
8177
0.97
0.40
2.5
2.5
g/l
65.1
66.1
2.80
707
7283
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
100
911
1.10
0.39
1.2
1.2
u/ml
4.5
4.3
0.04
44
289
(3026470) Cobalt [Mass/volume] in Blood
57
645
0.88
0.39
1.8
1.9
ug/l
3.8
3.7
0.04
51
566
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
61
1.31
0.39
3.3
4.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
153
1646
0.93
0.39
1.6
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.1
—
0
10
(40757373) Influenza virus identified in Isolate
15
193
0.78
0.39
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3747
37888
0.98
0.38
2.3
2.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
296
2813
1.05
0.38
1.1
1.1
titre
158.8
186.1
—
8
62
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
26
312
0.83
0.37
2.7
2.1
umol/l
53.8
57.8
0.36
26
242
(3025577) Chromium [Mass/volume] in Blood
56
631
0.89
0.37
1.9
2.0
ug/l
2.0
2.3
0.45
45
520
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
14
107
1.31
0.37
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
115
1247
0.92
0.37
1.3
1.3
u/l
17.6
10.6
2.94
87
997
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
116
0.69
0.36
1.4
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
37
429
0.86
0.36
1.5
1.5
%
1.9
3.7
—
9
101
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
14
180
0.78
0.36
1.4
1.5
ng/l
152.5
131.0
0.14
14
180
(3003888) Timothy IgE Ab [Units/volume] in Serum
54
609
0.89
0.36
1.0
1.1
u/ml
7.1
3.8
0.44
24
275
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
9
71
1.27
0.36
1.2
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
80
0.62
0.35
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
208
1.20
0.35
1.0
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
9
124
0.73
0.35
1.1
1.4
—
11.8
—
0
6
(3004775) Volume in Urine collected for unspecified duration
85
775
1.10
0.34
2.0
2.2
ml
722.1
637.3
0.72
45
500
(3023419) Bacteria identified in Sputum by Culture
110
1190
0.92
0.34
2.9
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
155
0.77
0.33
1.1
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
6
46
1.30
0.33
1.2
1.3
pmol/l
17.1
21.1
—
6
33
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
19
155
1.23
0.32
1.1
1.8
ug/l
2.5
2.2
—
9
78
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
11
83
1.33
0.32
2.5
2.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
25
295
0.85
0.31
1.2
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1036
10588
0.98
0.31
4.3
4.8
%
32.8
33.1
0.33
666
6942
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
219
0.82
0.31
2.1
2.6
—
—
—
0
0
(3016750) Collection duration of Urine
59
532
1.11
0.31
2.2
2.1
min
495.4
496.5
0.03
36
381
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
120
1119
1.07
0.30
1.1
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
84
1.31
0.30
9.7
11.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
102
1.27
0.30
1.5
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
57
515
1.11
0.29
1.1
1.2
u/l
195.9
94.5
0.72
49
440
(3042010) Triglyceride [Moles/volume] in Pleural fluid
19
157
1.21
0.29
1.2
1.2
mmol/l
1.9
1.5
0.14
12
101
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
130
0.77
0.29
12.5
12.2
mmol/l
6.8
5.2
—
10
130
(3000060) B lymphocytes [#/volume] in Blood
17
139
1.22
0.29
1.2
1.9
e6/l
2300.0
1117.6
—
9
68
(44806118)
101
939
1.08
0.28
1.2
1.4
—
—
—
0
0
(44790047)
101
939
1.08
0.28
1.2
1.4
—
—
—
0
0
(44790049)
101
939
1.08
0.28
1.2
1.4
—
—
—
0
0
(44790048)
101
939
1.08
0.28
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
712
7293
0.97
0.27
1.3
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
20
168
1.19
0.27
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
61
557
1.10
0.26
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
19
159
1.20
0.26
1.9
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
137
1451
0.94
0.26
1.3
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
149
1410
1.06
0.26
2.1
2.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
65
708
0.92
0.26
1.2
1.4
g/l
0.4
0.4
0.07
49
502
(3028192) IgG subclass 2 [Mass/volume] in Serum
65
708
0.92
0.26
1.2
1.4
g/l
2.7
2.9
0.36
49
503
(3027135) IgG subclass 1 [Mass/volume] in Serum
65
708
0.92
0.26
1.2
1.4
g/l
6.8
7.0
0.14
49
499
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
95
1.26
0.26
1.9
1.7
umol/l
49.7
43.7
0.30
12
95
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
71
0.70
0.26
1.0
1.1
u/l
8.2
10.4
—
5
71
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
1.0
1.3
—
—
—
0
0
(44806071)
5
75
0.67
0.25
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
75
0.67
0.25
1.2
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
73
1.23
0.25
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
15
123
1.22
0.25
1.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
55
502
1.10
0.25
1.1
1.2
u/l
43.8
25.6
0.73
47
419
(3003338) MCHC [Mass/volume]
6116
60864
1.01
0.24
39.8
22.0
g/l
329.2
331.7
76.33
6066
60252
(3036048) Francisella tularensis Ab [Titer] in Serum
13
159
0.82
0.24
1.0
1.2
—
484.4
—
0
9
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
90
840
1.07
0.24
1.1
1.1
%
111.0
114.8
0.61
80
733
(3005011) Chlamydia sp Ab [Titer] in Serum
9
76
1.18
0.24
1.7
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
104
1107
0.94
0.24
1.3
1.4
u/ml
101.1
124.1
1.47
23
243
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
191
0.84
0.24
1.1
1.0
u/ml
1.2
0.8
—
6
48
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
126
0.79
0.24
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
111
1045
1.06
0.24
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
134
1270
1.06
0.23
1.2
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
64
591
1.08
0.23
1.7
2.1
%
33.0
40.6
—
7
64
(3038071) Oxygen [Partial pressure] in Mixed venous blood
22
190
1.16
0.23
5.0
8.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
76
708
1.07
0.22
1.2
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
354
3435
1.03
0.22
2.2
2.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.4
1.2
nmol/l
23.4
28.0
—
5
31
(3000285) Sodium [Moles/volume] in Blood
11
135
0.81
0.22
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
42
1.19
0.21
1.6
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
47
513
0.92
0.21
3.6
3.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3479
35044
0.99
0.21
4.9
5.4
ug/l
3.2
3.9
1.18
3017
31060
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
40
440
0.91
0.21
1.3
1.3
u/ml
0.2
1.5
2.59
22
231
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
101
0.79
0.21
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
41
450
0.91
0.21
1.4
1.4
nmol/l
0.3
0.2
0.37
26
327
(40757494) Bilirubin.total [Moles/volume] in Blood
54
498
1.08
0.21
2.6
2.1
umol/l
22.0
34.6
—
7
45
(3006567) Chloride [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
117
1.20
0.20
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
219
0.87
0.20
1.1
1.4
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
1761.4
—
0
14
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
18
208
0.87
0.20
2.0
2.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
49
1.22
0.20
1.3
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
100
1056
0.95
0.20
1.1
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
52
562
0.92
0.19
1.5
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
218
2104
1.04
0.19
3.0
2.7
mg/l
1.8
1.7
1.29
196
1878
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
24
212
1.13
0.19
2.2
2.3
mmol/l
8.2
7.8
0.15
14
136
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
19
218
0.87
0.19
1.2
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
14
165
0.85
0.19
1.5
1.9
mmol/l
1.2
1.2
0.31
14
160
(3044009) aPTT.lupus sensitive (LA screen)
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
301
0.90
0.18
1.7
1.9
umol/l
120.8
121.3
0.00
13
165
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
54
580
0.93
0.18
1.1
1.2
titre
84.3
138.0
—
7
103
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
20
227
0.88
0.18
1.3
1.9
%
32.9
30.0
0.28
20
208
(3003740) Influenza virus B Ag [Presence] in Specimen
66
619
1.07
0.18
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
66
703
0.94
0.18
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
53
493
1.08
0.17
2.3
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
174
0.86
0.17
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
96
1010
0.95
0.17
1.1
1.1
iu/ml
8741.4
1045.9
0.41
21
203
(3027923) C peptide [Moles/volume] in Serum or Plasma
47
435
1.08
0.17
1.2
1.3
nmol/l
1.2
1.2
0.15
38
329
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
91
1.21
0.17
6.6
5.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
161
1672
0.96
0.17
1.2
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
278
2858
0.97
0.17
1.6
1.6
titre
146.0
285.8
—
10
133
(3025315) Body weight
5
69
0.72
0.16
6.8
5.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
26
288
0.90
0.16
2.5
2.8
umol/l
30.8
28.6
0.58
16
215
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
177
1.13
0.16
1.4
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
272
2649
1.03
0.16
1.1
1.1
u/ml
2.3
1.6
—
9
42
(21494814) CD8 cells/100 lymphocytes in Specimen
34
312
1.09
0.15
2.0
2.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
77
0.78
0.15
1.0
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
149
1.14
0.15
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
42
452
0.93
0.15
1.0
1.0
u/ml
5.7
2.4
0.52
12
173
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
293
1.09
0.15
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
116
1113
1.04
0.15
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
111
1064
1.04
0.15
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
79
1.14
0.15
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
49
523
0.94
0.15
1.1
1.0
u/ml
2.2
1.7
—
9
123
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
53
564
0.94
0.15
6.1
5.0
u/ml
37.7
73.2
1.02
13
162
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
192
0.89
0.14
1.2
1.1
—
—
—
0
0
(44806420)
35
323
1.08
0.14
2.4
2.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
20
223
0.90
0.14
1.4
1.4
—
1605879.2
—
0
12
(3020874) Milk IgE Ab [Units/volume] in Serum
18
202
0.89
0.14
1.1
1.1
u/ml
1.3
1.3
—
7
67
(46235355) HIV 1 and 2 tests - Meaningful Use set
786
7756
1.01
0.14
1.4
1.6
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
8
97
0.82
0.13
1.1
1.5
mu/l
4197.8
399.1
—
8
91
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
8
98
0.82
0.13
1.1
1.5
%
72.8
72.2
—
8
92
(3014051) Protein [Presence] in Urine by Test strip
195
1896
1.03
0.13
2.5
2.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
100
0.80
0.13
1.9
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
128
0.86
0.13
1.1
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
26
284
0.92
0.13
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
33
356
0.93
0.13
1.1
1.0
u/ml
1.6
0.2
—
5
99
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
9
106
0.85
0.13
3.8
2.6
—
81.0
—
0
18
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
35
376
0.93
0.13
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
190
0.89
0.13
1.5
1.6
ug/l
10.3
9.5
0.39
17
190
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
384
1.07
0.12
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
84
805
1.04
0.12
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
171
1.11
0.12
1.0
1.3
%
94.3
82.1
—
9
90
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
28
303
0.92
0.12
1.8
1.9
ug/l
69.5
55.6
0.88
28
292
(3011412) CD3 cells [#/volume] in Blood
67
702
0.95
0.12
1.9
2.1
e9/l
1.2
1.1
0.18
45
433
(3034426) Prothrombin time (PT)
23
210
1.10
0.12
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
45
424
1.06
0.12
7.3
6.1
—
—
—
0
0
(4024509)
90
867
1.04
0.11
1.7
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
157
0.89
0.11
1.1
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
99
956
1.04
0.11
3.9
3.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
12
105
1.14
0.11
2.0
2.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
86
892
0.96
0.10
1.2
1.3
mosm/kgh2o
275.1
277.9
0.54
67
670
(3011985) Renin [Units/volume] in Plasma
100
1034
0.97
0.10
1.3
1.4
mu/l
62.8
58.8
0.07
86
914
(3050129) First trimester maternal screen panel - Serum or Plasma
22
239
0.92
0.10
1.3
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
22
202
1.09
0.10
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
142
1457
0.97
0.10
1.3
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
197
0.91
0.09
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
106
1.13
0.09
2.1
2.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
80
828
0.97
0.09
1.1
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
116
1.12
0.09
1.1
1.1
u/ml
0.9
0.7
—
7
49
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
228
2321
0.98
0.09
2.4
2.3
ug/min
138.7
111.3
0.31
124
1348
(3008536) Aspergillus sp Ab [Presence] in Serum
18
165
1.09
0.08
1.4
1.8
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
57
1.05
0.08
2.5
3.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
42
400
1.05
0.08
1.1
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
107
1.12
0.08
2.0
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
129
1259
1.02
0.08
1.2
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
88
1.14
0.08
3.3
4.9
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
65
1.08
0.08
1.4
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
36
342
1.05
0.08
1.3
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
33
313
1.05
0.07
1.6
1.5
umol/l
11.7
13.1
0.10
24
218
(3015183) Erythrocyte sedimentation rate
23
215
1.07
0.07
1.3
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
137
1.09
0.07
2.1
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
77
1.04
0.07
1.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
84
0.83
0.07
1.4
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
84
0.83
0.07
1.4
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
84
0.83
0.07
1.4
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
428
0.96
0.07
1.4
1.6
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
7
85
0.82
0.07
1.0
1.2
—
55.3
—
0
6
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
122
0.90
0.07
1.3
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
206
1.07
0.07
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
206
1.07
0.07
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
64
620
1.03
0.07
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
34
356
0.95
0.06
1.1
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
207
1.06
0.06
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
207
1.06
0.06
1.4
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
162
0.93
0.06
1.5
1.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
13
119
1.09
0.06
3.1
1.3
%
109.7
107.9
0.06
13
113
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
172
0.93
0.06
1.2
1.2
umol/24h
0.7
0.7
—
8
78
(4198724)
12
131
0.92
0.05
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
491
4872
1.01
0.05
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
188
1.06
0.05
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
90
1.11
0.05
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
53
515
1.03
0.05
1.8
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1900
18942
1.00
0.05
3.6
4.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
107
1052
1.02
0.04
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
146
1479
0.99
0.04
1.2
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
170
1.06
0.04
1.0
1.2
%
91.6
82.7
—
8
86
(3035933) Granulocytes/100 leukocytes in Blood
12
129
0.93
0.03
1.3
1.6
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
22
210
1.05
0.03
1.2
1.3
nmol/l
95.5
143.7
1.82
15
152
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
31
321
0.97
0.03
1.5
1.7
nmol/l
6.0
5.9
0.01
25
273
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
220
0.95
0.03
1.6
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
131
1.07
0.03
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
50
488
1.02
0.03
1.4
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
187
1888
0.99
0.03
3.7
3.8
mg/l
32.6
29.4
0.50
117
1235
(3004616) Nuclear Ab [Presence] in Serum
90
914
0.98
0.03
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
125
1265
0.99
0.03
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
171
1.05
0.03
1.3
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
29
300
0.97
0.03
1.4
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
199
0.95
0.03
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
52
531
0.98
0.03
1.7
2.0
%
14.4
16.0
0.25
19
205
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
23
221
1.04
0.03
1.3
1.3
%
29.9
34.3
0.24
17
143
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
251
1.04
0.02
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
25
259
0.97
0.02
1.4
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
43
420
1.02
0.02
1.0
1.1
u/ml
5.0
2.5
0.60
15
160
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
70
711
0.98
0.02
1.3
1.2
nmol/l
1.3
1.5
0.78
63
630
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
172
1.05
0.02
1.4
1.4
—
—
—
0
0
(4306422)
88
869
1.01
0.02
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
25
258
0.97
0.02
1.2
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
26
268
0.97
0.02
4.8
5.4
%
65.5
71.5
0.51
20
209
(3051593) INR in Capillary blood by Coagulation assay
53
539
0.98
0.02
12.5
11.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
278
0.97
0.02
1.2
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
235
2362
0.99
0.01
1.4
1.4
iu/ml
15.0
18.4
—
8
52
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
36
368
0.98
0.01
1.3
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
137
0.95
0.01
1.2
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
683
6845
1.00
0.01
3.5
3.8
ng/l
98.6
96.8
0.18
588
5736
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
43
422
1.02
0.01
2.2
2.8
u/l
224.2
208.8
0.26
43
417
(3000093) Morphology [Interpretation] in Blood Narrative
91
919
0.99
0.01
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
89
881
1.01
0.01
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
187
0.96
0.01
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
52
528
0.98
0.01
1.1
1.3
promille
1.1
1.2
0.27
39
406
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
50
493
1.01
0.01
1.4
1.4
u/l
42.1
32.8
0.84
40
401
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
15
154
0.97
0.00
4.5
7.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
107
1.03
0.00
1.1
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
235
0.98
0.00
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
58
582
1.00
0.00
1.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
14
145
0.97
0.00
1.1
1.1
umol/l
17.8
16.4
1.04
14
130
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
96
962
1.00
0.00
1.2
1.3
pmol/l
265.6
297.0
0.34
70
730
(4212803)
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
10
99
1.01
0.00
7.1
5.2
ug/min
55.6
47.8
—
10
79
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
205
0.98
0.00
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
21
207
1.01
0.00
1.2
1.2
mmol/l
1.4
1.6
0.27
11
129
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
179
1.01
0.00
1.5
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
17
168
1.01
0.00
1.0
1.3
mg/l
1.2
58.2
0.79
12
129
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
78
0.90
0.00
1.4
1.2
umol/24h
1.6
1.8
—
7
78
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
5.2
—
11.7
—
0
6
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.8
—
0.3
—
0
6
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
97
0.93
0.00
1.0
1.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
59
1.02
0.00
1.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
79
0.89
0.00
1.3
1.3
—
555.0
—
0
11
(3043614) Bacteria identified in Aspirate by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.5
—
0
5
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
140.8
—
0
7
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
79
0.89
0.00
2.0
1.4
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
55
0.91
0.00
1.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
-0.00
0.0
1.2
—
1.4
—
0
9
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_COLORECTAL – Colorectal cancer
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).